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Saccular intracranial aneurysms 
(sIAs) are balloon-like vascular 
bulges that develop at branching 
points of intacranial arteries in ap-
proximately 3% of the population 
during life. The rupture of sIA wall 
is the most frequent cause of aneu-
rysmal subarachnoid hemorrhage 
(aSAH), a devastating form of stroke 
that mainly affects the working-age 
population. This study is a part of the 
long-term research effort of Kuopio 
sIA Database to characterize Eastern 
Finnish sIA disease.  In the present 
study, we used an overall cohort of 
2904 consecutive sIA patients from 
1980 to 2007 to analyze temporal pat-
terns of aSAH incidence and the role 
of type 2 diabetes and hypertension 
in sIA disease.
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ABSTRACT 
Saccular intracranial aneurysms (sIAs) form during life at the branching sites of 
intracranial arteries. Rupture of sIA (sIA-SAH) is the most frequent cause of 
aneurysmal subarachnoid hemorrhage. The Kuopio sIA Database 
(www.uef.fi/ns) contains all cases of unruptured sIA(s) and sIA-SAH admitted 
to Kuopio University Hospital (KUH) since 1980 in Eastern Finland. The 
purchases of prescribed medicines by sIA patients (1994-2008) were obtained 
from the national registry. (I) In a cohort of 1862 sIA-SAH patients (1980-2007), 
Sunday and Monday were the most frequent and Saturday the least frequent 
weekday on which SAH occurred. We could not identify any etiology to this 
temporal pattern, and age or gender did not correlate with the Sunday and 
Monday peaks. (II) In a cohort of 1058 sIA-SAH and 484 unruptured sIA 
patients (1995-2007), 9% used antidiabetes medication. The incidence of type 2 
diabetes did not significantly differ between the groups, suggesting that type 2 
diabetes does not increase the risk of sIA-SAH. (III) In a cohort of 1053 sIA-SAH 
and 467 unruptured sIA patients (1995-2007), 90% of the unruptured sIA 
patients presented with hypertension, smoking, or familial sIA. 
Antihypertensive medication was more frequent in the unruptured group (73% 
vs. 62%), with higher age-adjusted incidence. Untreated hypertension was more 
frequent in the sIA-SAH group at sIA diagnosis (29% vs. 23%). Size of 
unruptured sIAs increased with age at sIA diagnosis, independently of 
hypertension. Our results suggest that drug-treated hypertension is associated 
with the formation of sIA pouches rather than their rupture. Our study stresses 
the importance of blood pressure control in carriers of unruptured sIAs. 
 
National Library of Medical Classification: Intracranial Aneurysm [C10.228.140.300.510.600] 
Medical Subject Headings: Intracranial Aneurysm; Subarachnoid Hemorrhage; Type 2 Diabetes 
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TIIVISTELMÄ 
Sakkulaarinen intrakraniaalinen aneurysma (sIA) muodostuu kallonsisäisten, 
aivojen pinnalla olevien valtimoiden haarautumiskohtiin noin 3%:lla väestöstä. 
Aneurysmaattinen subaraknoidaalivuoto (aSAV), joka johtuu lähes aina sIA:n 
puhkeamisesta (sIA-SAV), on aivoverenkiertohäiriön muoto, joka kohdistuu 
pääasiassa työikäiseen väestöön. Kuopion Aneurysmarekisteri (www.uef.fi/ns) 
sisältää kaikki aSAV- ja sIA-potilaat, jotka ovat tulleet hoitoon Kuopion 
yliopistolliseen sairaalaan (KYS) vuodesta 1980 lähtien. Reseptilääkkeiden 
ostotiedot on yhdistetty aneurysmarekisteriin kansallisesta tietokannasta. (I) 
Vuosina 1980–2007 1862 sIA-SAV–potilaan kohortissa sunnuntai ja maanantai 
olivat yleisimmät ja lauantai oli harvinaisin vuotopäivä. Syy esiintyvyyden 
vaihtelulle ei selvinnyt ja ikä ja sukupuoli eivät vaikuttaneet 
esiintyvyyshuippuihin. (II) 1058 sIA-SAV potilaasta ja 484 vuotamattomasta 
sIA-potilaasta (1995–2007) 9 % oli käyttänyt diabeteslääkkeitä. Ryhmien välillä 
ei ollut merkittävää eroa diabeteksen ikävakioidussa ilmaantuvuudessa, mikä 
viittaa siihen, että tyypin 2 diabeteksella ei ole vaikutusta sIA-SAV:n 
esiintyvyyteen. (III) 1053 aSAV-potilaan ja 467 vuotamattoman sIA-potilaan 
kohortissa (1995–2007) verenpainelääkityksen käyttö oli yleisempää (73 % vs. 62 
%), ja verenpaineen ikävakioitu ilmaantuvuus oli suurempi vuotamattomilla. 
Ainoastaan 10% vuotamattomista potilaista ei käyttänyt verenpainelääkitystä, 
tupakoinut tai kuulunut aneurysmasukuun. sIA-SAV-potilailla oli enemmän 
hoitamatonta verenpainetautia ennen aneurysmadiagnoosia (29 % vs. 23 %). 
Vuotamattoman sIA:n koko lisääntyi iän myötä, verenpaineesta riippumatta. 
Löydöksemme osoittaa että lääkehoidettu verenpaine liittyy ensisijaisesti sIA:n 
muodostumiseen. Hoitamaton verenpainetauti voi altistaa aSAV:lle. 
Tuloksemme korostavat verenpaineen hoidon tärkeyttä anerysmapotilailla.  
 
Luokitus: C10.228.140.300.510.600 
Yleinen Suomalainen asiasanasto: aneurysma, esiintyvyys, aivot, aivotutkimus, valtimot, 
aivoverenvuoto, verenpaine, diabetes, aivovaltimoaneurysma 
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1 Introduction 
Saccular intracranial aneurysms (sIA) are balloon-like vascular bulges 
that develop at branching points of intacranial arteries in approximately 
3% of the population during life (1,2). Most of them do not rupture and 
are too small to cause neurological symptoms by mass effect. If 
diagnosed during life, most unruptured sIAs are incidental findings in 
neuroimaging for other causes or screening for familial sIAs. Aneurysmal 
subarachnoid hemorrhage (aSAH) is a devastating form of stroke that 
mainly affects the working-age population, unlike brain infarction and 
intracerebral hemorrhage (3,194). The annual incidence of SAH is 4-7 per 
100 000 worldwide but is over twice as high as this in Finland and Japan 
(4). Approximately 95% of aneurysmal subarachnoid hemorrhages are 
caused by the rupture of the sIA wall (sIA-SAH) (3). sIA disease is a 
complex trait, affected by acquired and genomic risk factors. Known risk 
factors include age, female sex, smoking, hypertension, and excess 
drinking (5). At least 10% of aSAH patients are familial (8,9). Five 
susceptibility loci for aSAH have been identified in genome-wide 
association studies (GWAS) (6,7). 
Temporal patterns in the incidence of hemorrhagic stroke, including 
SAH, have been analyzed in several studies. Incidence peaks of SAH 
have been reported at the weekend (10), on Sundays (11), and on 
Mondays (12-15). A consistent etiology for these peaks has not been 
identified but association with lifestyle-related factors has been proposed 
(11,12). Binge drinking is an independent risk factor in hemorrhagic and 
ischemic strokes (16). In Finland, binge drinking is common as Finns 
become drunk in 20% of instances of alcohol use which is concentrated at 
the weekends (17). 
Type 2 diabetes is a complex trait which affects the arterial wall 
through several different mechanisms (18-21). Type 2 diabetes is a well-
established risk factor for brain infarction and may predispose to 
intracerebral hemorrhage (22-24). However, the association between type 
2 diabetes and the sIA disease has remained unclear.  
Hypertension, a complex trait that also affects the arterial wall (25,26), 
is a strong risk factor for brain infarction and intracerebral hemorrhage 
(23). Antihypertensive medication is the key method in their primary and 
secondary prevention (27). Hypertension strongly associates with 
angiographically verified sIA-SAH when compared to matched controls 
or the general population (28-33). However, few studies have compared 
 
 
 
2 
hypertension in unruptured sIA carriers against aSAH cases or 
unaffected controls (34-36). 
Neurosurgery of Kuopio University Hospital (KUH) solely provides 
full-time acute and elective neurosurgical services for the KUH 
catchment area in Eastern Finland (Figure 1.1). KUH Neurosurgery 
maintains a database (www.uef.fi/ns) on all cases of aSAH or unruptured 
IAs admitted to KUH since 1977, retrospectively from 1977 to 1989, and 
prospectively from 1990. We have studied the phenotype (9), familial 
form (8,9), outcome (37-39), concomitant diseases (40), and genomics of 
sIA disease (6,7).   
Figure 1.1 Map of the catchment area of the Kuopio University Hospital 
(KUH), containing 4 central hospitals in Joensuu, Jyväskylä, Mikkeli, and 
Savonlinna. Population in this area is approximately 840 000. The areas of 
the four other university hospitals in Helsinki, Oulu, Tampere, and Turku are 
also delineated.  
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This study is a part of the long-term research effort of Kuopio sIA 
Database to characterize Eastern Finnish sIA disease. We used an overall 
cohort of 2904 consecutive sIA patients from 1980 to 2007. Data of all 
purchased prescribed medicines from 1994 to 2008 were obtained from 
the national registry. We analyzed the following aspects of Eastern 
Finnish sIA disease:  
 
(I)  Temporal patterns of aSAH incidence 
(II)  Impact of type 2 diabetes on the risk of sIA-SAH  
(III)  Impact of hypertension on the sIA disease 
The present study will contribute to the understanding of the 
epidemiology of sIA disease and the role of concomitant diseases in the 
formation, growth and rupture of sIAs.  This will support the design of 
appropriate diagnostic, preventive and follow-up actions for unruptured 
sIA carriers and ruptured sIA patients in the future.  
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2  Review of the Literature 
2.1 SACCULAR INTRACRANIAL ANEURYSM DISEASE 
2.1.1 Definition of saccular intracranial aneurysm 
Saccular intracranial aneurysms are balloon-like pouches that form 
during the course of life in the forks of intracranial extracerebral arteries, 
usually at the Circle of Willis or its proximity (3,41). Rupture of the sIA 
wall is the most common cause of non-traumatic subarachnoid 
haemorrhage (3).   
sIA is the dominant form of aneurysm of the intracranial arteries 
whereas fusiform (spinde-like) dilatation of the artery trunk is dominant 
in the aorta.  In the KUH sIA Database, only 4% of intracranial 
aneurysms are fusiform (9).  
2.1.2 Anatomy of intracranial extracerebral arteries 
The brain is supplied with arterial blood flow from two internal carotid 
arteries (ICA) and two vertebral arteries (VA). The ICAs bifurcate into 
the anterior (ACA) and middle cerebral arteries (MCA), together forming 
the anterior circulation of the brain. The ACAs are interconnected by the 
anterior communicating artery (ACoA). The posterior circulation of the 
brain consist of the basilar artery (BA), formed by the coinciding VAs, 
and their branches. The anterior and posterior circulations are connected 
by the posterior communicating arteries (PCoA) (Fig 2.1). 
The intracranial arteries consist of three layers: the tunica intima, 
tunica media and tunica adventitia. In comparison to the extracranial 
arteries, intracranial arteries lack the external elastic lamina (part of 
tunica media) and their tunica adventitia layer is weak (42,43). 
5 
 
 
 
Figure 2.1 Schematic representation of the Circle of Willis (modified from 
Wikipedia). 
2.1.3 Prevalence of sIAs 
In a systematic review from 2011, the prevalence of sIAs was estimated to 
be 3.2% globally in the population with 50% of males and a median age 
of 50 years, without comorbidities (1). The estimate is higher than the 
previous estimates of approximately 2% (2,44). The incidence of SAH is 
over twice as high in Finland and in Japan as in other western countries 
(4).  The prevalence of sIAs is not higher in Finland (1,2) which indicates 
elevated risk of sIA rupture in Finland. The large size of sIA and the 
location in the posterior circulation associate with rupture, but their 
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distribution in the Finnish sIA population does not differ from other 
western populations, suggesting other risk factors for the higher 
incidence of sIA-SAH in Finland (1,9).  
 In the present Finnish population of 5,426,674 (Statistics Finland, data 
from 12/2012), 3.2% represents approximately 174 000 individuals 
carrying unruptured sIA disease. The prevalence of sIAs and the 
incidence of sIA-SAH increase with age (1,4), being very rare in children 
and adolescents (1,4,47,177). Over 10% of sIA cases have a familial 
background (8,9,45).  
2.1.4 Pathobiology and hemodynamics of sIA  
The evidence from epidemiological studies and retrospective and 
prospective clinical series indicate that sIAs are not congenital but form 
during life in the forks of intracranial extracerebral arteries. sIAs are very 
rare in children and adolescents (1,4,47,177). The formation of de novo 
sIAs in adults has been angiographically confirmed in clinical follow-up 
series (48-50,174,190). In experimental animal models, sIAs are induced, 
for example, by a combination of hypertension and disruption of 
collagen synthesis (46).  
Approximately 95% of intracranial extracerebral artery aneurysms 
take the form of saccular pouches in the arterial forks (3,194). Other types 
include fusiform (51), mycotic (52) and traumatic (53) aneurysms. To the 
present knowledge, sIA develops when the wall of the artery becomes 
too weak to resist the hemodynamic stress, eventually causing the 
dilatation and, in some cases, rupture (41).  
The wall of an unruptured sIA may show myointimal hyperplasia and 
organizing luminal thrombus (41). The wall of a ruptured sIA, 
immediately resected after microsurgical clipping, is characterized by 
decellularized, degenerated matrix and a poorly organized luminal 
thrombus (41). Endothelial dysfunction in the sIA wall, possibly caused 
by aberrant flow conditions, may initiate cellular pathological processes 
that may eventually lead to a rupture-prone degenerated sIA wall (41, 
178-182).  
There is evidence that the processes of sIA formation and sIA wall 
rupture are at least partly separate and may have different risk factors (9, 
41,178-182).  
Hemodynamic factors are suggested to be important in the process of 
sIA formation. Computational fluid dynamics (CFD) modeling suggests 
that the branching points of intracranial arteries carrying sIAs are subject 
to complex hemodynamic forces (56), which may induce pathological 
remodeling of the sIA wall, transmitted by endothelial cells (41,57,58).  
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2.1.5 Genomics of sIA disease 
sIA disease is a complex trait, affected by genomic (59), epigenomic and 
environmental risk factors (5). At least 10% of patients carry familial sIA 
disease (9,60). The only monogenic disease significantly predisposing to 
sIA disease is autosomal dominant polycystic kidney disease (ADPKD) 
(44). Up to 10% of ADPKD patients develop  sIA(s), but only 1% of sIA-
SAH patients carry ADPKD (45,61). However, Marfan’s syndrome, 
which predisposes patients to fusiform aneurysms of the aorta, does not 
associate with sIA disease (64). The rare Ehlers-Danlos type IV also 
predisposes to fusiform aneurysms only (62,63).  
Genome-wide association studies have identified 5 significant 
susceptibility loci with to sIA disease and several other with suggestive 
association to the sIA disease (6,7,68-70). 9p21, the first sIA locus 
identified in a multinational cohort, also associates with coronary artery 
disease and aortic aneurysm (69).  
In the Nordic Twin Cohort, the concordance for SAH diagnoses from 
national hospital discharge registers was only 3.1% in monozygotic twins 
and 0.27% in dizygotic twins, but data for unruptured sIA cases was 
unavailable (71). Korja et al. estimate a heritability of 41% for aSAH,  
emphasizing the role of environmental factors (71).  They suggest that 
familial clustering of modifiable risk factors, e.g., smoking, high blood 
pressure, and heavy alcohol consumption, significantly contribute to 
familial SAH. Others have estimated that modifiable risk factors account 
for six to seven but genetic factors for only one of every ten SAHs (3,45).  
2.1.6  Risk factors for sIA disease 
Age 
The prevalence of sIA and incidence of sIA-SAH increase with age (1,4,8). 
The median age of sIA-SAH is between 50 and 60 years (4). In a meta-
analysis of 20 studies reporting incidences of aSAH per age-group, the 
overall incidence was 13.9 (95% CI 13.3 to 14.5) per 100,000 person years. 
With the age group 45–55 years as the reference, the incidence ratio 
increased from 0.10 (0.08 to 0.14) for the age group less than 25 years to 
1.61 (1.24 to 2.07) in the age group over 85 years (4). 
Female sex 
Women are overrepresented in most sIA cohorts. In a recent large meta-
analysis, the prevalence ratio (PR) of sIA for women compared with men 
was 1.61 (1.02–2.54), with a ratio of 2.2 (1.3–3.6) in the study populations 
with a mean age of more than 50 years (1). In younger patients the 
gender difference was not evident. It has been hypothesized that 
menopause could affect the pathogenesis of sIA disease. In addition, the 
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number of aneurysms larger than 5mm was higher in study populations 
with more women, which might partly explain the higher incidence of 
rupture in women, because large size associates with sIA rupture (1).  
The incidence of aSAH is approximately 1.6 times higher in women 
than in men (4), but the difference becomes apparent at 55 years and 
increases thereafter (4). The etiology of the female dominance in aSAH is 
not clear. Hormonal mechanisms, including the use of hormone 
replacement therapy for treatment of menopause, have been proposed 
(72,73). The fact that the gender difference becomes apparent so late 
seems to support this theory (4). 
Smoking  
Smoking is the most important modifiable risk factor of sIA disease 
(35,49,74,75). Smoking is the strongest risk factor of aSAH both in case-
control and prospective studies (5,36,45,78-80). Smoking increases the 
risk of aSAH in both sexes, but the impact may be stronger in women 
(81). Smoking may have a synergistic effect on aSAH risk with 
hypertension (78), and it also may enhance the effect of other known risk 
factors (82).  Current smoking is a stronger risk than prior smoking, but 
even prior smoking increases aSAH risk compared to nonsmoking (5). 
Smoking may be associated with the risk of rupture of small (diameter < 
3mm) sIAs (83). Vlak et al. suggest that smoking is not a trigger factor for 
aSAH but has a long-term role in the process leading to sIA wall rupture 
(84).  
Smoking has been proposed to induce the growth of sIAs (75,85) and 
to induce inflammation in the sIA wall (86-88), making it more prone to 
rupture. Smoking induces multiple molecular mechanisms that are 
possibly involved in the sIA wall pathobiology, including 
atherosclerosis, hemodynamic stress, endothelial dysfunction, vascular 
smooth muscle cell remodeling, and chronic inflammatory reaction 
(88,89). Further studies are required to clarify the effect of smoking and 
smoking-induced inflammation in sIA pouch formation and sIA wall 
rupture.  
Hypertension 
Previous data indicate that hypertension is a strong modifiable risk factor 
for aSAH (5), but evidence for its role in sIA formation has remained 
scarce. 
In angiographically verified sIA series, hypertension has strongly 
associated with aSAH when compared to matched controls or the general 
population (28-33), suggesting that hypertension predisposes to sIA wall 
rupture. Few series have compared unruptured sIA patients to controls 
or to sIA-SAH patients (28,34-36). In a case-control study of 250 
aneurysmal SAH patients (25% hypertensive) and 206 unruptured IA 
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patients (38% hypertensive) from the Netherlands, hypertension was not 
a significant risk factor for aneurysm rupture (36). In a Japanese case-
control study, 53% of the 858 ruptured and 58% of the 285 unruptured 
sIA patients had a history of hypertension until sIA diagnosis as 
compared to 30% in 798 controls (28). The author concluded that 
hypertension associates with the formation of sIA pouches rather than 
their rupture.  
In the UCAS Japan Study, 43% of the 5720 unruptured sIA patients 
(91% incidental; mean age 62.5 years; 68% women; no previous SAH) had 
a history of hypertension before angiographic sIA diagnosis (90). 
Hypertension did not significantly associate with subsequent rupture of 
sIAs (HR 1.41; CI95% 0.96–2.07). In the multinational ISUIA study, 41% 
of the 4060 angiographically verified unruptured sIA patients had a 
history of hypertension before angiographic diagnosis (91). Hypertension 
was not a significant risk factor for sIA rupture either. In a recent study 
of 206 unruptured IA patients and 574 controls from the Netherlands, 
38% and 19% had a history of hypertension, respectively. Hypertension 
was a significant risk factor for unruptured intracranial aneurysm in 
multivariate analysis (OR 2.9;1-4.6) (35). 
Familial sIA disease 
Familial aggregation of sIA disease has been confirmed in several 
populations (8,92-95). At least 10% of aSAH patients have a familial 
background (9,45). In the KUH population 1980-2007, 28% of the 
unruptured sIAs and 14% of the ruptured sIAs had a familial 
background (9). Familial sIAs tend to rupture at a younger age than 
sporadic ones (9,93,96). In sIA families with at least two affected 
members the prevalence of unruptured sIAs is approximately 10%, 
significantly higher compared to the general population (97). The 
estimated risk of aSAH for a sIA family member is 4.4-6.6 times higher 
than in the general population (96). 
Alcohol 
Excess use of alcohol is a risk factor for hemorragic stroke in general and 
aSAH in particular (5,16). The impact on aSAH incidence is evident in 
both sexes and independent of smoking, age and hypertension (5,10). 
The impact of excess use of alcohol is lower than that of smoking: 11-21% 
of aSAH cases are attributed to heavy use of alcohol (>150g/week) (45). 
The mechanisms by which excess use of alcohol increases the incidence 
of aSAH are unclear.  
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Migraine 
A recent case-control study suggested migraine as an independent risk 
factor for sIA rupture (82). Migraine was not considered as a trigger 
factor for aSAH but as a risk factor for weakening of the sIA wall (84). 
Characteristics of sIA 
The risk of rupture is higher for sIAs located in the posterior circulation 
than those in the anterior circulation of the brain (44,90,91). The most 
frequent sIA location is the MCA bifurcation, whereas the AcomA is the 
most frequent location for ruptured sIA, suggesting different etiologies 
for formation and the rupture (9,98). 
Size of sIA is independently associated with the rupture. (44,90,91). In 
the large ISUIA and UCAS studies, the cumulative rupture rate with no 
prior aSAH was significantly lower in sIAs smaller than 7mm when 
compared to sIAs larger than 7mm (90,91). Reliable assessment of the 
rupture risk for small (<7mm) sIAs remains a challenge in clinical 
practice. Growth of an unruptured sIA during follow-up  associates with 
subsequent rupture (75). Aneurysms with a secondary pouch – an 
irregular protrusion of the wall of the aneurysm – are at increased risk of 
rupture, independent of other risk factors (90).  
2.2 ANEURYSMAL SUBARACHNOID HEMORRHAGE 
2.2.1 Incidence of aSAH 
There is a wide variation in reported aSAH incidences worldwide. 
Globally, the incidence was 9.1 per 100,000 person years in a large 
systematic review from 2007 (4). The highest incidences have been 
reported in Japan and Finland, 22.7 and 19.7 per 100,000 person years, 
respectively (4). The lowest incidences are from South and Central 
America, 4.2 per 100,000 person years (4). The median age of onset was 
between 50 to 60 years (4).  
The incidence of aSAH has decreased over the past decades, consistent 
with the trend of decreasing overall stroke incidence in high-income 
contries (99). However, the decrease in aSAH incidence seems to be 
slower than in stroke in general (4). 
2.2.2 Temporal patterns of aSAH incidence 
Seasonal, monthly, weekly and daily patterns in hemorrhagic stroke have 
been analyzed in several studies. A meta-analysis from 2002 concluded 
that there are circannual, circaseptan and circadian patterns in the 
occurrence of SAH (11). 
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Most such studies have reported a peak of SAH incidence in winter 
and spring. Incidence patterns of respiratory infections (100) have been 
proposed to contribute to the seasonal variation (11). Behavioural 
responses to climatic conditions such as indoor smoking or increased 
alcohol intake have also been suggested (11). The effect of climatic 
conditions on physiological responses, mainly BP, have been 
investigated, but no consistent etiology for the seasonal variation of 
aSAH occurrence has been verified (101-108).  
Weekly patterns in SAH incidence have been recognized. Peaks of 
incidence have been reported at the weekend (10), on Sundays (11) or on 
Mondays (12-15). Trigger effects connected to changes in diet, alcohol 
intake and physical activity during weekends have been suggested as 
contributing factors. The beginning of a new working week on Monday 
could cause stress-related physiological changes in the body, triggering 
aSAH incidents (14,15). 
A circadian pattern with two peaks (morning and afternoon) of aSAH 
occurrence has been recognized in multiple studies (109-115). Circadian 
variation of blood pressure has been suggested as a trigger factor 
contributing to this incidence pattern (111,113,116). 
2.3 DIAGNOSIS, TREATMENT AND OUTCOME OF SIA 
DISEASE 
2.3.1 Diagnosis and occlusive therapy 
Unruptured sIA 
Unruptured sIAs are rarely large enough to cause focal neurological 
symptoms or symptoms of brain ischemia by seeding emboli. Almost all 
are found incidentally during neuroimaging of the head with unrelated 
indications. A minority of sIAs are found by screening members of sIA 
families. 
Occlusive therapy to prevent possible later sIA-SAH is recommended 
over conservative treatment for sIAs larger than 7mm (117,122). On the 
other hand, many ruptured sIAs are smaller than 7mm (9,123). Overall, 
the risk analysis of the pros and cons of preventive occlusive therapy and 
its mode requires careful analysis of, for example, patient characteristics 
(age, comorbidities, degree of anxiety, etc.), sIA characteristics (site, size,  
angioarchitecture, etc.) and preferences of the neurovascular team.  
aSAH 
Most sIAs are discovered when they present as aSAH. Typical symptoms 
of aSAH include severe headache with a sudden onset and persisting 
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exposure. The headache is often accompanied by symptoms of 
meningeal irritation such as vomiting, photophobia and stiff neck.  
Seizures and various focal neurological symptoms may appear. The 
severity of aSAH varies from almost symptomless to sudden death. So-
called warning leaks may preceed and go unnoticed before fulminant 
aSAH (173). The Hunt and Hess scale and Word Federation of 
Neurological Surgeons grading scale are the most commonly used 
clinical grading scales for SAH patients (192, 193). The clinical suspicion 
of  SAH requires immediate verification or exclusion of SAH by CT, 
followed by spinal tap in case of negative CT but reasonable clinical 
suspicion. Catheter angiography or CT angiography is used to verify or 
exclude aneurysms and other vascular causes of bleeding (117).  
sIA-SAH is a severe systemic condition which requires neurointensive 
care. sIA-SAH patients are at immediate risk of rebleeding, so their sIAs 
should be verified and occluded promptly (117, 175). Occlusive therapy 
includes microsurgical clipping, endovascular coiling and stenting, and 
their combinations (118-121,176).  
2.3.2 Prevention of sIA formation and sIA wall rupture 
To date, there is no specific intervention to prevent the formation of sIAs. 
The avoidance or treatment of modifiable risk factors such as smoking 
and hypertension is important in the prevention of sIA-SAH (30). Treated 
hypertension may cease to be a risk factor for sIA-SAH (36). Cessation of 
smoking reduces the risk of SAH (124).  
Recent case-control studies suggest that hypercholesterolemia is 
associated with reduced risk of SAH (28,36,82). In the large UCAS Japan 
study, hyperlipidemia was associated with reduced risk of sIA rupture, 
but the effect was not significant (p=0.06) (90). The risk reduction was 
hypothesized to be mediated by the use of statins. Further research is 
required to clarify the possible effect of statins on the course of sIA 
disease.  
The screening of members of sIA families with at least two first degree 
relatives with sIA disease is recommended (71,126). 
2.3.3 12-month and long-term outcome of sIA-SAH 
Outcome after sIA-SAH has improved over past decades, but disability 
and mortality rates are still high, depending on the severity of sIA-SAH 
and the condition of the patient on admission to neurosurgical or 
neurointensive care (38, 127-129). Common possible complications 
include bleeding into the brain or ventricles, rebleeding, acute brain 
ischemia, hydrocephalus, seizures, electrolyte disturbances, 
cardiopulmonary dysfunction, and subacute cerebral ischemia (117,131).   
The overall mortality due to sIA-SAH is impossible to define 
accurately, but population-based studies suggest 50% (128,130). In a 
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recent study using Kuopio sIA database, the cumulative mortality of 
1657 sIA-SAH patients admitted to KUH within 24 hours was 27% at 12 
months, with advanced age, poor condition, hydrocephalus, intracerebral 
hemorrhage and intraventricular hemorrhage as significant risk factors 
after various time intervals from sIA-SAH (38). In a recent study by Korja 
et al., 12-month mortality was significantly higher in patients with known 
cerebrovascular risk factors, highlighting the importance of risk factor 
control in sIA patients (125).  
The long-term outcome of sIA-SAH survivors is marred by a 
multitude of possible complications of various severities, including 
epilepsy, declined cognition, depression, dementia, shunt complications, 
hypothalamic and hypophyseal disorders, and ischemic cerebrovascular 
events (183-189). In a recent study using the Kuopio sIA database, the 12-
month survivors of sIA-SAH presented with a 15% excess mortality at 15 
years as compared to a matched KUH cathcment population (37). 
Furthermore, the sIA-SAH patients presented with a increased risk of 
lung cancer during follow-up, suggesting continued smoking (40). 
2.4. CONCOMITANT DISEASES IN SIA CARRIERS 
2.4.1 Type 2 diabetes  
The diagnosis of diabetes is based on an elevated plasma fasting 
glucose level (≥ 7mmol/l) or the result of a 2h oral glucose tolerance test 
(≥ 11mmol/l) (134). Type 2 diabetes usually refers to diabetes diagnosed 
after the age of 35 years and is the most common type of diabetes 
covering approximately 70-80% of diabetic patients (134). Atherosclerosis 
is the most significant complicantion of the illness, i.e., coronary heart 
disease, arteriopathies of limbs, and stroke. The evidence from 
prospective and case-control clinical series indicate that type 2 diabetes is 
a strong risk factor for brain infarction (BI) (23,24,135,136) and may 
predispose to intracerebral hemorrhage (23,24).  
In recent case-control studies, the reported prevalence of type 2 
diabetes varied from 2 to 8% in aSAH patients (28,30,33,35,137-139). The 
prevalence is 4% to 14% in unruptured patients (28,35). Based on case-
control studies, it has been suggested that type 2 diabetes is a protective 
factor for SAH (28,29,140). However, in these studies the diagnosis of 
diabetes was based on self or proxy reports and not actual blood glucose 
levels. The prevalence of diabetes has rarely been studied in 
angiographically verified unruptured sIA patients, or compared between 
sIA-SAH patients and unruptured sIA patients. Two previous studies 
suggest that diabetes is not a risk factor for the formation of sIA (28,35).  
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Inagawa suggests that the protecting effect of diabetes could be 
connected to increased atherosclerosis in the cerebral arteries of diabetic 
sIA patients, stabilizing the sIA wall (28). Increased use of 
antihypertension and statin medication in sIA patients with type 2 
diabetes may also contribute to the risk reduction.   
In theory, a genomic link protecting from sIA disease and 
predisposing to type 2 diabetes could exist. Type 2 diabetes and aSAH 
are associated with the 9p21.3 locus, but not within the same LD block 
(6,19,68,69,141).  
2.4.2 Hypertension  
Cardiovascular morbidity and mortality both increase with increasing 
blood pressure values, without a definite cut-off value. The threshold 
value for the diagnosis of hypertension is considered to be 140/90 mmHg, 
which corresponds to a home measurement of 135/85 mmHg  (142,143). 
Hypertension is the most important risk factor for stroke in general and 
for hemorrhagic stroke in particular (23). Antihypertensive medication is 
the cornerstone of both the primary and secondary prevention of stroke 
(27).  
In animal models of intracranial aneurysms, externally induced 
hypertension is essential in the induction of aneurysm formation (46). 
Previous data has indicated that hypertension is also a strong risk factor 
for human sIA-SAH, but the role of hypertension in the formation of sIAs 
has remained unclear (5,78). A putative sIA risk locus at 5q26 associated 
with high systolic blood pressure (7).  However, the leading 
hypertension risk loci did not associate with the sIA disease in Finland 
(7). 
In recent angiographically confirmed sIA cohorts, the reported 
prevalence of hypertension varies from 38-51% in unruptured sIA 
patients and 34-53% in aSAH patients (28-36,90).  These prevalences were 
mostly based on self or proxy reports, and may not represent the actual 
prevalence of hypertension in sIA cohorts. Hypertension significantly 
associates with angiographically verified aSAH (28-33). However, few 
series have compared unruptured sIA patients with controls or with sIA-
SAH patients (28,34-36). These studies suggest that hypertension is a risk 
factor for sIA formation rather than rupture.  
The evidence of the role of hypertension in the risk of multiple sIAs 
and the growth of existing sIAs during follow-up is contradictory. 
Hypertension was significantly associated with sIA growth in a 
retrospective series of 53 sIAs (74), but not in a retrospective series of 165 
patients (144) and a prospective series of 87 patients (75). Hypertension 
was significantly associated with the presence of multiple (two or more) 
intracranial aneurysms in 392 ruptured patients (OR 1.9, 95% CI 1.5–3.5) 
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(77), but not in 298 ruptured and 121 unruptured patients (139), nor in 
266 ruptured patients (76). 
Presently, the mechanisms by which hypertension would affect the 
formation of sIAs are inadequately understood. Hypertension may 
induce endothelial dysfunction in the intracranial arteries, which has 
been suggested to be important in the process of sIA formation and 
rupture (41).  
2.5 EASTERN FINNISH SIA DISEASE 
2.5.1 Catchment population of Kuopio University hospital 
During the total time period covered in this study (1980 to 2007), the 
geographical area of the catchment population for Kuopio University 
Hospital (KUH) has remained unchanged. During the study period of 
1980-2007 (Publication I), the population decreased from 863,726 to 
851,066, and the median ages of females and males rose from 31 to 42 and 
34 to 45 years, respectively. During the study period of 1995-2007 
(Publications II and III), the population decreased from 880,914 to 
851,066,  and the median age increased from 38 to 42 years in males and 
from 41 to 45 years in females. The proportion of males has remained 
unchanged at 49%. 
2.5.2 Kuopio sIA Database (www.uef.fi/ns) 
Since 1977, the Neurosurgery of KUH has been the sole provider of full-
time acute and elective neurosurgery in KUH catchment area (Figure 
1.1). The KUH catchment area includes four central hospitals with their 
own CT scanners. Diagnosed SAH cases have been admitted to KUH for 
angiography and treatment if not very aged or moribound.  Patients 
diagnosed with sporadic or familial unruptured sIAs are also sent to 
KUH for consideration for the elective treatment of sIAs. In both 
instances, exact rejection numbers are not available. 
KUH Neurosurgery maintains a database of all aSAH cases or 
unruptured IAs admitted to KUH since 1980, retrospective until 1989 and 
prospective from 1990. The database was created by Juha Hernesniemi, 
since 1997 Professor and Chairman of Helsinki Neurosurgery. A 
dedicated full-time nurse interviews all new cases of sIA and aSAH, and 
collects clinical data. Clinical data from the hospital stays and follow-up 
visits are also entered. The use of prescribed medications (1994-2008) 
before and after sIA diagnosis, cancer and other hospital diagnoses, and 
causes of death have been entered from the national registries. The 
phenotype, genetics, and outcome of Eastern Finnish sIA disease have 
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been analysed in many local and collaborative studies (2,6-9,37-40,68-
70,191) (Table 2.1).  
 
 
 
Table 2.1 Previous PhD Theses on Eastern Finnish sIA disease 
 
Author Title Year 
Antti Tapaninaho 
Non-Ischemic Complications after Subarachnoid 
Hemorrhage and Aneurysm Surgery 
1994 
Jaakko Rinne 
Multiple Intracranial Aneurysms: Kuopio Experience on 
302 of 1.314 Patients 
1996 
Antti Ronkainen Familial Intracranial Aneurysms 1997 
Timo Koivisto 
Prospective Outcome Study of Aneurysmal Subarachnoid 
Hemorrhage: Endovascular versus Surgical Therapy 
2002 
Paula Bendel 
Imaging of the Brain after Aneurysmal Subarachnoid 
Hemorrhage: One-Year MRI Outcome of Surgical and 
Endovascular Treatment 
2009 
Stepani Bendel Pituitary and Adrenal Response to Critical Illness 2010 
Terhi Huuskonen 
Saccular Intracranial Aneurysm Disease in Eastern 
Finnish Population: Phenotype on Admission, Excess 
Mortality, Risk of Cancer 
2012 
 
2.5.3 Type 2 diabetes in the KUH catchment population 
In Finland, the prevalences of cardiovascular risk factors, including 
hypertension and smoking, have decreased during recent decades, but 
the prevalence of type 2 diabetes has rapidly increased (145). Globally, 
the prevalence of type 2 diabetes is expected to increase drastically 
during the coming decades (146).  
In a cross-sectional population-based survey in Finland between 
X/2004 and I/2005, the total prevalence of both previously diagnosed and 
screen-detected type 2 diabetes was 16% in men and 11% in women aged 
45-74 years (147). Data from another population-based study indicates 
that in 2004 in the Northern Savo region – part of the KUH cathment area 
– 3.6% of the total population received reimbursement for type 2 
diabetes, exceeding the national average of 3.1% (148).  
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2.5.4 Hypertension in the KUH catchment population 
The prevalence of hypertension in Finland is among the highest in 
western countries (149). In recent decades, average blood pressure levels 
in Finland have decreased (145). In the Finnish FINRISKI cohort in 2007, 
48% males and 28% of females aged 25 to 64 had hypertension (blood 
pressure ≥ 140/90 mmHg and/or ongoing antihypetertensive medication) 
(150). In North Karelia and Northern Savo, the parts of the KUH 
catchment area included in the FINRISKI cohort, the prevalences of 
hypertension were 53% and 55% in men and 39% and 35% in women, 
respectively (151). In particular, the percentage of hypertensive women 
was markedly higher than the national average. Only 26% and 38% of 
hypertensive men and 31% and 45% of hypertensive women were using 
antihypertensive medication (151). 
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3 Aims of the study 
3.1 TEMPORAL PATTERNS IN THE INCIDENCE OF SIA-
SAH 
To study temporal patterns in the incidence of sIA-SAH in the KUH 
catchment population from 1980 to 2007.  
3.2 IMPACT OF TYPE 2 DIABETES ON THE RISK OF SIA-
SAH 
To compare the prevalence and incidence of type 2 diabetes in 
unruptured sIA patients and sIA-SAH patients from 1995 to 2007 in the 
KUH catchment population, testing the hypothesis that type 2 diabetes 
predisposes to sIA-SAH. 
3.3 IMPACT OF HYPERTENSION ON THE SIA DISEASE  
To compare the prevalence and incidence of hypertension in unruptured 
sIA patients and sIA-SAH patients from 1995 to 2007 in the KUH 
catchment population, testing the hypothesis that hypertension 
predisposes to the formation of sIA rather than its rupture. 
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4 Increased incidence of Aneurysmal 
Subarachnoid Hemorrhage on Sundays and 
Mondays in 1,862 Patients from Eastern 
Finland  
ABSTRACT  
Background  
Temporal patterns of aneurysmal subarachnoid hemorrhage (aSAH) 
from saccular intracranial aneurysm (sIA) were studied in a consecutive 
series of 1,862 patients.  
Methods  
Neurosurgery of Kuopio University Hospital (KUH) solely serves a 
defined catchment population in Eastern Finland. Kuopio’s sIA database 
contains 1,596 sporadic and 266 familial patients admitted to KUH within 
72 h from the onset of aSAH between 1980 and 2007. The distributions by 
the weekday of the onset of aSAH, admission to KUH, and occlusive 
therapy of the ruptured sIA were analyzed. Logistic regression was used 
to search for clinical variables (patients, sIA disease, clinical condition) 
that would independently correlate with each distribution.  
Results 
 The onset of aSAH occurred significantly most often (p = 0.001) on 
Sundays (n = 330) and Mondays (n = 309) and least frequently on 
Saturdays (n = 231). None of the clinical variables tested associated 
significantly and independently with the Sunday and Monday peaks. 
The admissions to KUH after aSAH were most frequent (p = 0.001) on 
Mondays (n = 331) and least frequent on Thursdays (n = 221) and 
Saturdays (n = 221). Overall, 1,655 patients underwent occlusive therapy, 
most frequently on Mondays (n = 318) and least frequently on Saturdays 
(n = 189) and Sundays (n = 197).  
Conclusions 
Sundays and Mondays were the most frequent and Saturdays the least 
frequent days of aSAH in a defined Eastern Finnish population. We 
 
 
 
20 
could not identify any etiology to this temporal pattern. Binge drinking is 
frequent in Finland, especially among young males, but age and gender 
did not correlate with the Sunday and Monday peaks. 
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4.1 INTRODUCTION 
Aneurysmal subarachnoid hemorrhage (aSAH) from ruptured saccular 
intracranial aneurysm (sIA) is a devastating form of stroke that affects 
the working-age population (3). Some 2% of the population develops 
sIAs (2,5) but most do not rupture during the lifetime as the general 
annual incidence of SAH is 9/100,000 (4). The incidence of SAH is twice 
as high in Finland and in Japan (4). The sIA disease is a complex trait 
affected by genomic (6,69) and acquired risk factors (5), the mechanisms 
of which in the formation, progress and rupture of sIA pouches are 
poorly understood. Risk factors include age, female sex, smoking, 
hypertension, and excessive drinking (5), and at least 10% of aSAH 
patients have a family history (8,9,60).  
Daily variation in hemorrhagic stroke has been analyzed in several 
studies, with the peaks of SAH on the weekend (10), on Sundays (11), or 
on Mondays (12-15). No consistent etiology for these peaks has been 
identified, but association with lifestyle-related factors has been 
proposed (11,12). In Finland, binge drinking is common as Finns become 
drunk in 20% of instances of use, which is concentrated on weekends 
(17). Binge drinking is an independent risk factor in hemorrhagic and 
ischemic strokes (16), and in major cardiovascular events (152). We 
studied the distribution of aSAH by the weekday in a consecutive series 
of 1,862 patients admitted alive within 72 h from the onset of aSAH to 
Kuopio University Hospital (KUH), which solely serves a defined 
catchment population in Eastern Finland. 
4.2 PATIENTS AND METHODS 
4.2.1 Catchment Population of KUH 
During the study period from 1980 to 2007, the Neurosurgery units of 
KUH had solely provided full-time acute and elective neurosurgical 
services for the KUH catchment population in Eastern Finland (9). The 
KUH area contains four central hospitals with neurological units of their 
own. From 1980 to 2007, the geographic area remained the same, the 
population decreased from 863,726 to 851,066, the median age increased 
from 31 to 42 years in males and from 34 to 45 years in females, and the 
proportion of males remained unchanged at 49% (9). 
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4.2.2 Kuopio Intracranial Aneurysm Database 
All cases of SAH diagnosed by spinal tap or CT in the KUH catchment 
area are acutely admitted to KUH for angiography and treatment if not 
moribund or very aged. The exact number of rejected SAH patients is not 
available. KUH Neurosurgery maintains a database (Access) of all cases 
of ruptured and unruptured intracranial aneurysms admitted to the 
KUH since 1977. The database has been prospective since 1990, and 
earlier cases have been entered from the hospital records. The database is 
run by a dedicated full-time nurse, who interviews all new cases, and 
collects and codes into variables detailed information, including family 
history, the criterion for which is at least 2 affected first-degree relatives 
(9). Clinical data from the hospital periods and follow-up visits are 
entered. The use of prescribed medicines (1994–2008) before and after the 
sIA diagnosis, occurrence of cancer and other diagnosed diseases, and 
causes of death have been entered from the national registries. 
Phenotype, genetics, and the outcome of Eastern Finnish sIA disease 
have been previously analyzed in several local and collaborative studies 
(2,6,8,9,37,69,153,154,183,193). 
4.2.3 Study Population 
The basic study population (9) consists of 1,978 sporadic and 306 familial 
aSAH patients fulfilling the following criteria: 
(1) citizen of Finland and resident of the KUH catchment area at the time 
of first aSAH between January 1, 1980, and December 31, 2007; (2) 
admission alive to KUH, and verification of sIA by angiography or at 
autopsy; (3) aSAH from ruptured sIA. The present study population of 
1,596 sporadic and 266 familial aSAH patients fulfilled 2 additional 
criteria: (4) the exact date of aSAH registered; (5) admission to KUH 
within 72 h from the onset of aSAH.  
4.2.4 Follow-Up Data 
The death certificates with the ICD-9 or ICD-10 codes were obtained 
from Statistics Finland. All patients were followed up until either death 
or December 31, 2008, and no patient was lost from the follow-up. 
4.2.5 Variables 
The variables used in the multivariate analyses were the following 
(Table 4.1): (1) sIA disease carrier (gender; age at aSAH; sporadic vs. 
familial sIA patient); (2) sIA disease (location and diameter of the 
ruptured sIA; 1 vs. 2 or more sIAs); (3) condition on admission for aSAH 
to KUH (Hunt and Hess grade; intracerebral hemorrhage; 
intraventricular hemorrhage; acute hydrocephalus); (4) occlusive therapy 
of ruptured sIA (clipping vs. coiling vs. none); (5) outcome at 12 months 
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(Glasgow Outcome Scale); (6) referring central hospital (n = 4) in the 
KUH catchment area; (7) weekday, month, season and year of 4 events: 
birth; onset of aSAH; admission to KUH, and occlusive therapy of 
ruptured sIA. 
Table 4.1  Variables on admission of 1862 aneyrysmal subarachnoid 
hemorrage patients and their relation to Sunday or Monday as dates of onset 
of aneurysmal subarachnoid hemorrage in multivariate logistic regression 
analysis 
Variable Patients OR CI 95% 
Females 1014 (55%) 1 Ref 
Males 848 (45%) 1,022 0,824 – 1,268 
Member of sIA family 266 (14%) 1,199 0,899 - 1,597 
Multiple sIAs (≤2) 487 (26%) 1,180 0,936 - 1,487 
Age at aSAH years    
5 - 44  597 (32%) 1 Ref 
45 - 54  504 (27%) 0,929 0,711 - 1,214 
55 - 64  433 (23%) 0,918 0,693 - 1,216 
65 -  328 (18%) 0,767 0,550 - 1,068 
Referring health care unit    
KUH 444 (24%) 1 Ref 
Central hospitals at KUH area (n=4) 1083 (58%) 0,990 0,755 - 1,299 
Other 335 (18%) 0,861 0,617 - 1,202 
Period of aSAH    
1980 - 1989 580 (31%) 1 Ref 
1990 - 1999 739 (40%) 0,879 0,671 - 1,151 
2000 - 2007 543 (29%) 0,943 0,700 - 1270 
Time from aSAH to admission to KUH    
≤24 hours 1171 (70%) 1 Ref 
24 – 48 hours 487 (26%) 0,998 0,777 - 1,284 
49 – 72 hours 204 (11%) 0,941 0,658 - 1,348 
Hunt&Hess grade on admission to KUH    
I 134 (7%) 1 Ref 
II 740 (40%) 1,317 0,868 - 1,998 
III 499 (27%) 1,193 0,757 - 1,880 
IV 260 (14%) 1,834 1,093 - 3,076 
V 229 (12%) 1,577 0,832 - 2,988 
ICH on admission to KUH 507 (27%) 0,972 0,729 - 1,297 
IVH on admission to KUH 578 (31%) 0,951 0,732 - 1,237 
Hydrocephalus on admission to KUH    
moderate 647 (35%) 0,898 0,707 - 1,139 
severe 162 (9%) 0,852 0,554 - 1,308 
Location of ruptured sIA    
ACoA 555 (30%) 1 Ref 
Mbif 565 (30%) 0,885 0,658 - 1,190 
BAbif 71 (4%) 0,892 0,505 - 1,577 
Other 671 (36%) 1,002 0,775 - 1,295 
Diameter of ruptured sIA (n=1713)    
<7mm 659 (36%) 1 Ref 
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7-14mm 823 (44%) 0,870 0,693 - 1,092 
>14mm 231 (12%) 0,759 0,533 - 1,082 
Occlusive therapy of ruptured sIA    
clipping 1315 (71%) 1  Ref 
coiling 296 (16%) 0,948 0,697 - 1,289 
other 44 (2%) 1,304 0,669 - 2,540 
no occlusion 207 (11%) 0,932 0,562 - 1,544 
GOS at 12 months    
5 = good recovery 962 (52%) 1 Ref 
4 = moderate disability 292 (16%) 1,086 0,685 - 1,720 
3-2 = severe disability / vegetative state 134 (7%) 1,012 0,692 - 1,482 
1 = dead 475 (26%) 1,097 0,782 - 1,540 
aSAH = aneurysmal subarachnoid hemorrhage; sIA = saccular intracranial aneurysm; Ref = 
reference in multivariate analysis; KUH = Kuopio University Hospital; ICH = intracerebral 
hemorrhage; IVH = intraventricular hemorrhage; ACoA = anterior communicating artery; Mbif 
= middle cerebral artery bifurcation; BAbif = basilar artery bifurcation; GOS = Glasgow 
Outcome Scale. 
 
4.2.6. Statistical Analysis 
Medians were given for the continuous and ordinal variables. The 
distributions of the 4 events of interest (birth; onset of aSAH; admission 
to KUH; occlusion of ruptured sIA) by the weekday were presented in 
triplicate to better visualize possible time patterns. The chi-square test 
was used to analyze whether each event was distributed evenly by the 
weekday. Logistic regression was used to analyze which variables 
independently associated with the distribution of each event by the 
weekday, month and season, as well as to the outcome of the patients at 
12 months. All statistical analyses were performed using the Statistical 
Package for Social Sciences 17.0 for Windows. 
4.2.7 Ethical Aspects 
The study was approved by the Ethics Committee of KUH. The causes of 
death were obtained with the permission of the Ministry of Social Affairs 
and Health of Finland. 
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4.3 RESULTS 
4.3.1 Distribution of Birth by Weekday  
In the series of 1,862 patients admitted within 72 h after aSAH to KUH, 
an even distribution of the events of interest would make 266 per 
weekday. The birth dates, presented in triplicate in figure 4.1 , did not 
significantly cluster by the weekday (p = 0.731).  
4.3.2.Distribution of aSAH by Weekday 
The onset of aSAH occurred significantly more often (p = 0.000) on 
Sundays (n = 330) and Mondays (n = 309) than on the other weekdays, 
and least frequently on Saturdays 
(n = 231; fig. 4.1). None of the variables in table 4.1 correlated with the 
Sunday or Monday peaks in the univariate analysis or in the multivariate 
analysis. 
 
Table 4.2 Previous studies (10-15,113,155) on the onset of hemorrhagic 
strokes by weekdays 
Article ICH SAH Weekday of onset 
Pasqualetti, et al. 1990 159 - Weekend peak for ICH 
Juvela, et al. 1993 - 278 Weekend peak for SAH 
Vermeer, et al. 1995 - 385 No weekday variation for SAH 
Kelly-Hayes, et al. 1995 43 46 Monday peak for ICH and SAH 
Feigin, et al. 2002 - 2533 Sunday peak for SAH (meta-
l i )Wang, et al. 2002 2803 1229 Monday peak for ICH and SAH  
Turin, et al. 2007 384 169 Monday peak for SAH 
Lin, et al. 2008 6725 1321 Monday peak for ICH and SAH 
ICH = intracerebral hemorrhage; SAH = subarachnoid hemorrhage 
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Figure 4.1 Temporal patterns of subarachnoid hemorrhage (aSAH) from 
saccular intracranial aneurysm (sIA) in a defined population in Eastern 
Finland solely served by Neurosurgery of Kuopio University Hospital (KUH). 
The Kuopio sIA database contains 1596 sporadic and 266 familial sIA 
patients admitted to KUH within 72 hours from the onset of aSAH between 
1980 and 2007. The distributions by the weekday of (A) the onset of aSAH, 
(B) admission to KUH, and (C) occlusive therapy of the ruptured sIA are 
presented. The distribution of the birthdates of the 1862 patients by the 
weekday (D) are presented for comparison. All distributions are constructed 
into triplicates to better visualize possible temporal patterns. 
 
4.3.3.Admission to KUH and Occlusive Therapy by Weekday 
The admission to KUH after aSAH occurred more frequently (p = 0.000) 
on Mondays (n = 331) than on the other weekdays, and least frequently 
on Thursdays (n = 221) and Saturdays (n = 221; fig. 4.1). Overall, 1,655 
aSAH patients underwent occlusive therapy of the ruptured sIA, more 
frequently on Mondays (n = 318) than on the other weekdays, and least 
frequently on Saturdays (n =189) and Sundays (n = 197; fig. 4.1).  
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4.4 DISCUSSION 
 
We studied the temporal patterns of aSAH from ruptured sIA in the 
Eastern Finnish catchment population of KUH(9,37). The cohort 
consisted of 1,596 sporadic and 266 familial aSAH patients for whom the 
exact date of aSAH had been registered and who had been admitted to 
KUH within 72 h from the onset of aSAH. The incidence of aSAH was 
significantly higher on Sundays and Mondays and least frequent on 
Saturdays. In multivariate analysis, age, gender, familial disease, time 
period, intracerebral hemorrhage, intraventricular hemorrhage, 
hydrocephalus, or condition on admission did not correlate with the 
Sunday and Monday peaks.  
Daily variation in hemorrhagic stroke has been analyzed in several 
studies (Table 4.2), with the peaks of SAH on the weekend (10), on 
Sundays (11), or on Mondays (12-15). No consistent etiology for these 
peaks has been identified, but an association with lifestyle-related factors 
has been proposed (11-14). Publication bias may be a factor as studies 
showing no temporal pattern in SAH have not been published. 
Monthly incidence rates in hospitalization for nontraumatic SAH 
(ICD-8 code 430; ICD-10 code I60) between 1977 and 1995 were studied 
in Denmark using the national hospital discharge registry. Interestingly, 
there was a modest seasonal variation for hospitalization (peak-to-trough 
ratio = 1.07, 95% CI 1.0–1.12) with the fitted peak in January and the 
trough in July (156). In comparison to our study, the ICD codes also 
include cases of nonaneurysmatic SAH. The strength of the present study 
is the inclusion of the cases of aSAH from ruptured sIA only. Temporal 
patterns, if any, might be different with fusiform or mycotic intracranial 
aneurysms as well as in nonaneurysmal perimesencephalic SAH cases.  
Our large cohort on the weekday variation of aSAH hospitalization is 
based on the sIA registry (www.uef.fi/ns) of a single tertiary referral 
center with near-population-based inception and standard prospective 
collection of the clinical data.  
The weaknesses of the present study include no knowledge of the 
smoking and drinking habits of the patients. Consequently, the possible 
correlation of smoking and alcohol consumption to the Sunday and 
Monday peaks or Saturday lows of aSAH cannot be studied in the 
present cohort. In addition, only the 1,862 sIA patients with a known 
date of onset of aSAH and admission alive within 72 h of onset to KUH 
were included, excluding 422 otherwise eligible sIA carriers. 
Heavy alcohol consumption is a risk factor for all types of stroke (157), 
and the habit of binge drinking is considered as an additional 
independent risk factor (16). In Finland, the alcohol consumption per 
capita ratio was 10.2 in 2009 (158), the second highest in the Nordic 
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countries (159). Alcohol intake in Finland concentrates on the weekends, 
and the highest levels of binge drinking and drunkenness in the EU are 
found in Finland (159). Binge drinking is more frequent among young 
males, but age and gender did not correlate with the Sunday and 
Monday peaks in our study. 
In theory, the beginning of a new working week on Monday could 
cause stress-related physiological changes in the body, triggering aSAH 
incidents (14,15). This was supported by the finding in our cohort that 
age over retirement age diluted the Sunday and Monday peaks, although 
not significantly. Changes in physical activity between working days and 
weekends could also be a factor (160,161). 
4.5 CONCLUSIONS 
Sundays and Mondays were the most frequent and Saturdays the least 
frequent weekdays of aSAH in a defined Eastern Finnish population. In 
multivariate analysis, age, gender, familial disease, time period, 
intracerebral hemorrhage, intraventricular hemorrhage, hydrocephalus, 
or condition on admission did not correlate with the Sunday and 
Monday peaks. Further research is required to find out etiological factors 
for this temporal pattern. 
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5 Type 2 diabetes and risk of saccular 
intracranial aneurysm rupture in Eastern 
Finland 
ABSTRACT 
Objective  
Type 2 diabetes is a risk factor for other forms of stroke, but its 
association with subarachnoid hemorrhage (SAH) from ruptured 
saccular intracranial aneurysm (sIA) has remained unclear. 
Research design and methods 
Kuopio Intracranial Aneurysm Database (www.uef.fi/ns) includes all 
ruptured and unruptured sIA cases from a defined catchment population 
in eastern Finland since 1980. We compared the age-adjusted incidences 
of type 2 diabetes in 1,058 ruptured and 484 unruptured sIA patients 
during 1994–2008, using the national registry of prescribed medicine 
purchases. 
Results 
 Of the 1,058 ruptured sIA patients, 43% were males and 57% females, 
with a median age at rupture of 51 and 56 years, respectively. From 1994 
to 2008 or until death, 9% had been prescribed antidiabetes medication 
(ADM) with a median starting age of 58 years for males and 66 years for 
females. Of the 484 unruptured sIA patients, 44% were males and 56% 
females, with a median age at the diagnosis of 53 and 55 years, 
respectively, and 9% had used ADM, with a median starting age of 61 
years for males and 66 years for females. The incidence of type 2 diabetes 
was highest in the age-group 60–70 years, with no significant differences 
between the ruptured and unruptured sIA patients. 
Conclusions 
Our study suggests that type 2 diabetes does not increase the risk of 
rupture of sIA, which is by far the most frequent cause of nontraumatic 
SAH. 
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5.1 INTRODUCTION 
Aneurysmal subarachnoid hemorrhage (SAH) is a devastating form of 
stroke that affects primarily the working-age population (3). In ~95% of 
cases, SAH is caused by the rupture of a saccular intracranial aneurysm 
(sIA) at the fork of intracranial extracerebral arteries in contrast to their 
infrequent fusiform, mycotic, and traumatic aneurysms. Some 2% of the 
general population develops sIAs (2,5) during life, but most do not 
rupture, as the general annual incidence of SAH is 4–7 per 100,000 (4,99). 
The sIA disease is a complex trait, affected by genomic (6,68,69) and 
acquired risk factors (5), the mechanisms of which in the formation, 
progress, and rupture of sIA pouches are poorly understood. Risk factors 
include age, female sex, smoking, hypertension, and excess drinking (5), 
and at least 10% of ruptured sIA patients have a family history 
(8,9,37,60). In a genome-wide association study, susceptibility loci at 
2q33.1, 8q11.23, and 9p21.3 have been identified in Finnish subjects (68). 
Type 2 diabetes is a complex trait affecting the arterial wall through 
several different mechanisms (18-21). Type 2 diabetes is a well-
established risk factor for brain infarction and may predispose to 
intracerebral hemorrhage (22-24). Instead, the association between type 2 
diabetes and sIA disease has remained unclear. Three recent studies 
(28,29,140) and our present review of the literature suggest that diabetes 
is a protecting factor for rupture of sIA (Table 5.1; Fig. 5.1A) 
(30,32,33,137,138,162,163). Both type 2 diabetes and sIA disease are 
associated with the 9p21.3 locus, although not with the same LD block, 
but they do not seem to share other loci in genome-wide association 
studies. 
Kuopio Intracranial Aneurysm Database (www.uef.fi/ns) contains all 
cases of unruptured and ruptured sIAs admitted to the Kuopio 
University Hospital (KUH) from a defined eastern Finnish catchment 
population since 1980 (9,37). We have studied the phenotype (9), familial 
form (8,9), risk factors (164), outcome (37,38), concomitant diseases (37), 
and genomics of sporadic and familial sIA disease (6,68-70). Here, we 
investigated retrospectively whether type 2 diabetes predisposes to sIA 
rupture by comparing 1,058 ruptured sIA patients with 484 unruptured 
sIA patients with first diagnosis between 1995 and 2007. In this study, we 
tested the hypothesis that arterial long-term effects of type 2 diabetes 
predispose to the rupture of the sIA wall rather than the formation of the 
sIA pouch. We also performed a review of the literature of the published 
cohorts to summarize the previous data on the association of type 2 
diabetes and sIA disease. 
31
 
  
Ta
bl
e 
5.
1.
 P
re
vi
ou
s 
st
ud
ie
s 
on
 t
he
 a
ss
oc
ia
tio
n 
of
 d
ia
be
te
s 
an
d 
in
tr
ac
ra
ni
al
 a
ne
ur
ys
m
 d
is
ea
se
 s
in
ce
 2
00
1
 
 
R
ef
er
en
ce
  
C
ou
nt
ry
 
Ty
pe
 o
f 
st
ud
y 
C
as
es
 a
nd
 c
on
tr
ol
s 
M
ea
n 
ag
e 
±
 
S
D
 
D
M
 
ca
se
s 
(%
) 
A
ss
oc
ia
ti
on
 o
f 
D
M
 a
nd
  
  
  
 
IA
 d
is
ea
se
 
C
ri
te
ri
a 
of
 D
M
 
Ye
ar
 
S
hi
ue
 
A
us
tr
al
ia
 
C
as
e-
co
nt
ro
l 
43
2 
aS
A
H
 
56
.5
 ±
 
20
 (
5)
 
N
.s
. 
m
ul
tiv
ar
ia
te
 
M
ed
ic
al
 r
ec
or
ds
 
20
12
 
 
M
ul
tic
en
te
r 
47
3 
co
nt
ro
ls
 
 
37
 (
8)
 
 
 
C
ui
  
Ja
pa
n 
Pr
os
pe
ct
iv
e 
11
1 
aS
A
H
 
 
3 
(3
) 
N
.s
. 
m
ul
tiv
ar
ia
te
 
S
ee
 t
he
 r
ef
. 
20
11
 
 
M
ul
tic
en
te
r 
 
 
 
 
 
  
 
Fo
llo
w
-u
p 
12
 y
ea
rs
 
 
 
 
 
 
In
ag
aw
a 
 
Ja
pa
n 
C
as
e-
co
nt
ro
l 
79
8 
aS
A
H
 
64
 ±
 1
2 
37
 (
5)
 
O
R
 0
.4
1;
 0
.2
6-
0.
64
; 
p<
0.
00
1 
M
ed
ic
al
 r
ec
or
ds
 
20
10
 
 
S
in
gl
e 
ce
nt
er
  
79
8 
co
nt
ro
ls
 
 
72
 (
9)
 
 
 
 
 
 
26
6 
un
ru
pt
ur
ed
 s
IA
s 
66
 ±
 1
1 
37
 (
14
) 
N
.s
. 
fo
r 
un
ru
pt
ur
ed
 s
IA
s 
 
  
 
 
79
8 
co
nt
ro
ls
 
 
72
 (
9)
 
 
 
K
os
hy
  
In
di
a 
C
as
e-
co
nt
ro
l 
16
3 
aS
A
H
 
52
 ±
 1
1 
5.
5%
 
un
iv
ar
ia
te
 O
R
 0
.3
4;
 0
.1
5-
0.
76
; 
 
In
te
rv
ie
w
 
20
10
 
 
M
ul
tic
en
te
r 
15
0 
co
nt
ro
ls
 
 
14
.7
%
 
p=
0,
00
9 
 
R
ui
z-
S
an
do
va
l 
 
M
ex
ic
o 
R
et
ro
sp
ec
tiv
e 
  
 
23
1 
aS
A
H
 
52
 
16
 (
7)
 
O
R
 0
.3
4;
 0
.1
7-
0.
68
; 
p=
0.
05
 
M
ed
ic
al
 r
ec
or
ds
 
20
09
 
 
M
ul
tic
en
te
r 
 
23
1 
co
nt
ro
ls
 
 
35
 (
15
) 
 
 
O
hk
um
a 
 
Ja
pa
n 
C
as
e-
co
nt
ro
l 
39
0 
aS
A
H
 
58
 ±
 1
3 
23
 (
6)
 
N
.s
. 
un
iv
ar
ia
te
 
S
tr
uc
tu
re
d 
 
20
03
 
 
M
ul
tic
en
te
r 
 
39
0 
co
nt
ro
ls
 
 
31
 (
8)
 
 
qu
es
tio
nn
ar
e 
K
is
se
la
  
U
S
A
 
C
as
e-
co
nt
ro
l 
10
7 
aS
A
H
 
 
5.
6%
 
N
.s
. 
un
iv
ar
ia
te
 
In
te
rv
ie
w
 a
nd
  
20
01
 
 
M
ul
tic
en
te
r 
 
19
7 
co
nt
ro
ls
 
 
9.
1%
 
 
m
ed
ic
al
 r
ec
or
ds
 
Q
ur
es
hi
 
U
S
A
 
C
as
e-
co
nt
ro
li 
32
3 
aS
A
H
 
52
.7
 ±
 
14
25
 (
8)
 
N
.s
. 
m
ul
tiv
ar
ia
te
 
S
tr
uc
tu
re
d 
20
01
 
 
S
in
gl
e 
ce
nt
er
 
96
9 
co
nt
ro
ls
 
 
10
1 
(1
0)
 
qu
es
tio
nn
ai
re
 
K
ub
ot
a 
 
Ja
pa
n 
C
as
e-
co
nt
ro
l 
12
7 
aS
A
H
 
52
 ±
 1
0 
2 
(2
) 
N
.s
. 
un
iv
ar
ia
te
 
S
tr
uc
tu
re
d 
20
01
 
  
M
ul
tic
en
te
r 
 
12
7 
co
nt
ro
ls
 
  
4 
(3
) 
  
qu
es
tio
nn
ai
re
 
aS
A
H
=
an
eu
ry
sm
al
 s
ub
ar
ac
hn
oi
d 
he
m
or
rh
ag
e;
 I
A
=
in
tr
ac
ra
ni
al
 a
ne
ur
ys
m
; 
sI
A
=
sa
cc
ul
ar
 in
tr
ac
ra
ni
al
 a
ne
ur
ys
m
; 
D
M
=
di
ab
et
es
 m
el
lit
us
; 
N
.s
. =
si
gn
ifi
ca
nt
;O
R
=
od
ds
 r
at
io
 in
 m
ul
tiv
ar
ia
te
 a
na
ly
si
s.
 *
Th
e 
ty
pe
 o
f 
in
tr
ac
ra
ni
al
 a
ne
ur
ys
m
, 
w
he
th
er
 s
ac
cu
la
r 
vs
. 
fu
si
fo
rm
, 
m
yc
ot
ic
 a
nd
 
tr
au
m
at
ic
, 
w
as
 n
ot
 a
lw
ay
s 
av
ai
la
bl
e 
in
 t
he
 r
ef
er
re
d 
co
ho
rt
s 
32 
 
 
5.2 RESEARCH DESIGN AND METHODS 
5.2.1 Catchment population of KUH  
During the study period from 1995 to 2007, Neurosurgery of KUH had 
solely provided full-time acute and elective neurosurgical 
services for the KUH catchment population in eastern Finland. The KUH 
area contains four central hospitals with neurologic units of their own. 
From 1995 to 2007, the geographic area remained the same but the 
population decreased from 880,914 to 851,066. The median age increased 
from 38 to 42 years in males and from 41 to 45 years in females, and the 
proportion of males remained unchanged at 49% (9). 
5.2.2 Kuopio Intracranial Aneurysm Database 
All cases of SAH diagnosed by spinal tap or computed tomography in 
the KUH catchment area have been acutely admitted to KUH for 
angiography and treatment if not moribund or very aged. Cases with 
unruptured intracranial aneurysm(s) but no SAH have also had 
neurosurgical consultation for elective occlusion. They were detected 
mostly as incidental findings in neuroimaging for other causes, less often 
as symptomatic, or by screening sIA family members. The findings were 
confirmed by four-vessel catheter angiography, magnetic resonance 
angiography (MRA), or computed tomography angiography (CTA). The 
exact numbers of rejected cases are not available. KUH Neurosurgery 
maintains a database on all cases of unruptured and ruptured 
intracranial aneurysms admitted to the KUH since 1980. The database 
has been prospective since 1990, and earlier cases have been entered from 
hospital records. The database is run by a dedicated fulltime nurse, who 
interviews all new case subjects, and collects and codes variables with 
detailed information, including the family history. The criterion for an 
sIA family is at least two affected first-degree relatives(9). Clinical data 
from the hospital periods and follow-up visits are entered. The use of 
prescribed medications (1995–2008) before and after the sIA diagnosis, 
occurrence of cancer and other diagnosed diseases, and causes of death 
have been entered from national registries. The phenotype, genomics, 
and outcome of eastern Finnish sIA disease have been analyzed in 
several studies (2,6,9,37,39,68-70). 
5.2.3. Study population 
The inclusion criteria were citizenship of Finland and residence in the 
KUH catchment area at first diagnosis of sIA disease between 1 January 
1995 and 31 December 2007; admission alive to KUH, and verification of 
sIA(s) by angiography or at autopsy. The exclusion criteria were rupture 
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of an intracranial aneurysm other than a saccular one (e.g., fusiform, 
traumatic, mycotic) or any other vascular malformation. 
5.2.4 Antidiabetes or antihypertension medication 
The diagnosis for type 2 diabetes was made based on the database of 
purchased antidiabetes drugs. The Social Insurance Institution of Finland 
maintains a nationwide registry of all prescribed drugs purchased from 
the pharmacies since 1994. Information on purchases of all prescribed 
drugs by the 1,542 sIA patients between 1 January 1994 and 31 December 
2008 was obtained from the Social Insurance institute of Finland and 
linked to Kuopio Intracranial Aneurysm Database. The recruitment 
period, from 1 January 1995 to 31 December 2007, allows data on 
purchased drugs for at least 1 year before and 1 year after the diagnosis 
of sIA. Antidiabetes (ADM) and antihypertension medications were 
classified according to the anatomic therapeutic chemical (ATC) 
classification system. The patients with type 1 diabetes, first identified 
according to their insulin use and by their special reimbursement code 
and finally verified from the case reports, were excluded from the 
analysis. 
5.2.5 Variables 
The variables used in the analyses were as follows for all sIA patients: 1) 
sIA disease carrier (sex, age at first sIA diagnosis or at rupture of sIA, 
sporadic vs. familial sIA patient, use and starting age of antihypertensive 
medication, and use and starting age of ADMs) and 2) sIA disease 
(location and diameter of the primary sIA and one versus two or more 
sIAs. 
5.2.6 Statistical analysis 
Univariate analyses were performed using the Mann-Whitney U test. 
Multivariate analyses were performed using the binomial logistic 
regression model. To account for difference of age at the diagnosis of sIA 
disease between the unruptured and ruptured groups, we standardized 
the age to the joint age distribution of both age-groups. Standardized 
rates and CIs were calculated according to the methodology of Fay and 
Feuer(165), as the occurrences of diabetes are low in different age-groups. 
The incidences of ADM in the ruptured and unruptured patients were 
calculated for 10-year age intervals, and the CIs in each age group were 
calculated as exact central Poisson CIs(166). 
5.2.7 Review of the literature 
A PubMed search for articles on SAH risk and diabetes was made from 
2001 to April 2012 with the following keyword(s): subarachnoid 
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hemorrhage, stroke, diabetes, and case-control. Bibliographies of the 
retrieved articles were examined for further relevant publications. 
Crosschecking was continued until no further publications in English 
were found. Only the studies that reported the number of patients 
exposed to diabetes, allowing recalculation of the associated SAH risk, 
were included. Studies restricted to subgroup of patients (e.g., young 
patients) were excluded. When there were multiple studies from the 
same cohort, the newest published study was included. A fixed-effects 
Mantel-Haenszel method was used in the review of the literature to 
estimate pooled odds ratios (ORs) and CIs. The appropriateness of fixed-
effects model was evaluated by the Cochran Q test, which indicated no 
heterogeneity of study effects (Q = 3; df = 7; P = 0.7). 
5.2.8 Ethics 
The study was approved by the ethicscommittee of the KUH. Data fusion 
from the national registries was performed with the approval from 
Ministry of Social Affairs and Health of Finland. 
5.3 RESULTS 
5.3.1 Unruptured sIA disease 
Of the 1,542 sIA patients, 484 (31%) carried an unruptured sIA disease 
(Table 5.2). There were 211 (44%) males and 273 (56%) females, and their 
median ages at the first diagnosis were 53 and 55 years, respectively. The 
most frequent sIA location was the middle cerebral artery bifurcation 
(48%). Two or more sIAs were diagnosed in 127 (26%) patients. Familial 
sIA disease was found in 123 (25%) patients. Of the 484 patients, 224 
underwent microsurgical and 56 endovascular occlusion therapy of 
sIA(s). 
5.3.2 ADM in unruptured sIA patients  
During the observation period for drug usedfrom 1994 to 2008 or deathd 
43 (9%) of the 484 unruptured sIA patients used ADM. The median 
starting age was 61 years for the 22 males and 66 years for the 21 females. 
The ADM had been started before the sIA diagnosis in 14 (31%) cases 
and after the diagnosis in 31 (69%) cases. In multivariate analysis, only 
the age at diagnosis (OR 1.03 [95% CI 1.012–1.051, P = 0.01) 
independently associated 
with ADM. 
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5.3.3 Ruptured sIA disease 
There were 1,058 ruptured sIA patients, 451 (43%) of whom were male 
and 607 (57%) female, with median ages at first rupture of sIA of 51.0 and 
56.0 years, respectively (Table 5.2). The most frequent location of 
ruptured sIA was the anterior communicating artery at 29%. Two or 
more sIAs were diagnosed in 298 (28%) patients. Familial sIA disease 
was carried by 145 (14%) patients.  
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Table 5.2 Clinical characteristics and anti-diabetic medication of 1542 sIA 
patients admitted to Kuopio University Hospital 1995-2007 
  
Unruptured sIA 
disease             
n=484   
Ruptured sIA disease  
n=1058 
  
 
 
  
No ADM   ADM      
Univar 
iate p No ADM    ADM      
Univar 
iate p 
sIA patients 441 (91) 43 (9)    968 (91) 90 (9) 
   females 252 (57) 21 (49) n.s. 557 (58) 51 (55) n.s. 
ADM 441 (91) 43 (9)    968 (91) 90 (9) 
   median starting age 
(quartiles)   64 (57-70)     62 (53-68) n.s. 
   before sIA diagnosis   14/43 (33)     30/90 (33) n.s. 
   after sIA diagnosis   29/43 (67)      60/90 (67) 
Antihypertensive medication 327 (74) 33 (73) 0.006 596 (62) 82 (89) <0.000 
   median starting age 
(quartiles) 53 (47-64) 59 (49-63) n.s. 54 (46-65) 59 (51-66) 0.007 
   before sIA diagnosis 206 (47) 32 (74) 0.001 307 (32) 43 (48) 0.002 
   after sIA diagnosis 121 (27) 22 (26)    289 (30) 47 (52) 
Antihypercholesterolemic 
medication 194 (44) 28 (65) 0.008  245 (25) 58 (64) <0.000 
   median starting age 
(quartiles) 58 (51-66) 66 (56-68) n.s. 58 (53-67) 62 (56-68) 0.05 
   before sIA diagnosis 80 (41) 15 (54) n.s. 88 (36) 14 (25) n.s. 
   after sIA diagnosis 114 (59) 13 (46) n.s. 157 (64) 44 (75) n.s. 
sIA disease diagnosis       
   median age (quartiles)  54 (46-64) 63 (55-69) 0.001 53 (45-64)  61 (51-69) <0.000 
   familial sIA disease 117 (27) 6 (14) n.s. 133 (14) 12 (13) n.s. 
   multiple sIAs 121 (27) 6 (14) n.s. 272 (28) 26 (28) n.s. 
Age at sIA diagnosis (years)       
   – 44 87 (20) 1 (2)   242 (25) 13 (14) 
   45 – 54 146 (33) 9 (21)   279 (28) 17 (19) 
   55 – 64 100 (23) 14 (33)   225 (23) 26 (29) 
   65 – 108 (25) 19 (44)   222 (23) 34 (38) 
Location of sIAs Unruptured sIAs Ruptured sIAs  
   ICA 147 (24) 11(20) n.s. 208 (21) 22 (24) n.s. 
   ACoA 68 (11) 5 (9) n.s. 238 (29) 29 (32) n.s. 
   A2-5 22 (4) 4 (7) n.s. 52 (5) 4 (4) n.s. 
   Mbif 253 (41)  20 (36) n.s.   279 (29) 21 (23) n.s. 
   VA  11(2) 3 (5)  n.s. 32 (3) 6 (7) n.s. 
   BAbif  31(5) 5 (9) n.s.  50 (5) 2 (2) n.s. 
   Others  80(13) 8 (14) n.s.  64 (7) 8 (9) n.s. 
   Median size (mm)     8,4 (n=968) 7,9 (n=92) n.s. 
Data are n (%). Site distribution by all unruptured sIAs not by sIA patients. A2–5, 
distal segments of anterior cerebral artery; ACoA = anterior communicating artery; 
BAbif = basilar artery bifurcation; ICA, internal carotid artery; Mbif, middle cerebral 
artery bifurcation; n.s., not significant; VA, vertebral artery. 
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5.3.4 ADM in ruptured sIA patients  
From 1994 to 2008 or death, 90 (9%) of the 1,058 ruptured sIA patients 
used ADM. The median starting age was 58 years for the 40 (44%) males 
and 66 years for the 50 (56%) females. The ADM had been started before 
the rupture in 30 (33%) cases and after the rupture in 60 (67%) cases. In 
multivariate analysis, the age at rupture (OR 1.05) associated 
independently with ADM. The cumulative mortality rate at 12 months 
after the rupture of sIA was 25%. 
In multivariate analysis of all 1,542 sIA patients, familial sIA (OR 0.42), 
sIA in middle cerebral artery bifurcation (0.24), sIA in basilar artery 
bifurcation (0.23), sIA in “other” location (0.38), antihypercholesterolemic 
medication (0.49), and antihypertension medication (0.57) independently 
associated with rupture of sIA, while ADM did not (Table 5.3). 
 
 
Table 5.3 Risk factors for sIA rupture in 1544 sIA patients in binomial logistic 
regression analysis 
  p OR CI95% 
Familial sIA 0.001 0.42 0.31 - 0.56 
Location of sIA     
* ACoA   1   
* Mbif 0.001 0.24 0.17 - 0.34 
* BAbif 0.001 0.23 0.13 - 0.40 
* others 0.001 0.38 0.27 - 0.54 
Antihypertensive medication 0.011 0.69 0.53 - 0.92 
Antihypercolesterolemic medication 0.001 0.49 0.38 - 0.63 
Antidiabetes medication 0.37 1.21 0.80-1.83 
ACoA, anterior communicating artery; aSAH, aneurysmal subarachnoid hemorrhage; BAbif, 
basilar artery bifurcation; IVH, intraventricular hemorrhage; Mbif, middle cerebral artery 
bifurcation 
5.3.5 ADMs used 
Between 1994 and 2008, the 133 patients with ADM used 22 different 
drugs according 
to the anatomic therapeutic chemical classification. During the study 
interval, the most frequently used ADMs were as follows: metformin and 
other oral ADM (n = 96), insulin combined with oral ADM (n = 29), and 
monotherapy with insulin (n = 7). 
5.3.6 Incidence of type 2 diabetes 
The age-standardized incidence of type 2 diabetes was 6.36 (4.60–8.63) 
per 1,000 follow-up years for patients with unruptured sIA and 6.98 (95% 
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CI 5.62–8.59) per 1,000 follow-up years for patients with ruptured sIA. 
The incidence of type 2 diabetes was highest in the group of 60– 70 years, 
with no significant differences between the ruptured and unruptured 
patients (Fig. 5.1B). 
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Figure 5.1 A: Review of the literature of the association of diabetes and SAH 
in case-control studies published 2001–2012. The horizontal lines represent 
the 95% CIs of the OR or risk ratios (RRs). The size of the black box 
indicates the relative effect on the final fixed-effect estimate. The x-axis is 
logarithmic. B: Incidence of type 2 diabetes in 1,058 ruptured (aneurysmal 
SAH) and 484 unruptured sIA patients by age-group and 95% CIs. 
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5.4 DISCUSSION 
We tested the hypothesis that type 2 diabetes would increase the risk of 
sIA rupture by comparing 1,058 ruptured sIA patients and 484 
unruptured sIA patients first diagnosed between 1995 and 2007 in a 
defined eastern Finnish population. The type 2 diabetic patients were 
identified by ADM usage between 1994 and 2008, obtained from the 
Finnish registry of prescribed drug purchases. The ADM usage, 9% in 
both cohorts, did not associate with the rupture of sIA in multivariate 
analysis. 
Type 2 diabetes is a well-established risk factor for brain infarction 
and may predispose to intracerebral hemorrhage (22-24). Instead, the 
association between type 2 diabetes and sIA disease has remained 
unclear. Unlike our study and the cohort of 329 cases of SAH from sIA 
published in 1984 (167), three recent studies (28,29,140) and our present 
review of the literature from the six published ones suggested that 
diabetes is a protective factor for SAH (Table 5.1; Fig. 5.1). Inagawa 
hypothesized that the protecting effect of diabetes would be connected to 
enhanced atherosclerosis in the sIA wall, making it less prone to rupture 
(28). Atherosclerosis has not been identified as an independent risk factor 
for saccular aneurysms that form in the branching sites of intracranial 
extracerebral arteries (5) unlike in fusiform aneurysms, e.g., in the aorta 
(168). In theory, a genetic link that predisposes to the development of 
type 2 diabetes and lowers the risk of developingsIAs may exist. 
Hypercholesterolemia was associated with reduced risk of SAH in three 
case-control studies (40% risk reduction), with no clear sex difference(5). 
Another theoretical protective factor in diabetic patients might be more 
efficient diagnosis and treatment of hypertension and independent risk 
factor ofthe sIA disease (5). In the present cohort, the median ages for 
diagnosis of the sIA disease were 54 years for the unruptured cases and 
54 years for the ruptured sIA cases. Instead, the median starting age for 
ADM was 63 and 62 years, respectively. Consequently, the impact of 
diabetes on arterial walls may manifest so late that it does not show in 
the sIA disease. 
Type 2 diabetes and sIA disease are complex traits with genomic 
components. The 9p21.3 locus associates with both diseases 
(68,69,141,169) but not in the same linkage disequilibrium block. To our 
knowledge, other shared susceptibility loci have not been found, 
suggesting that type 2 diabetes and sIA disease do not share genomic 
predisposition. 
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Unfortunately, the sIA registry does not contain reliable data on BMI, 
smoking, or drinking habits of the sIA patients. An obvious weakness 
was also the lack of data on the diagnostic tests used for type 2 diabetes 
such as fasting glucose levels and oral glucose tolerance tests. On the 
other hand, we compared the ruptured sIA patients with the unruptured 
sIA patients, and both had their blood glucose levels studied during the 
hospitalization for the sIA disease. In ruptured sIA patients, these 
glucose levels are unreliable because of impact of ruptured sIA and its 
neurointensive care. Of the 133 ADM users, as many as 81 had started 
ADM within 12 months after the sIA diagnosis. Still, we may have 
missed cases of unmedicated diabetes during the period of ADM 
purchases, and the vascular effects of diabetes may be different in 
medicated and untreated individuals. In a cross-sectional population-
based survey in Finland between October 2004 and January 2005, the 
total prevalence of both previously diagnosed and screen-detected type 2 
diabeteswas 16% in men and 11% in women aged 45–74 years (147). 
Previous studies registered the diabetes status only once, missing 
diabetes cases presenting after the sIA diagnosis. The strengths of the 
current study derive from the Finnish health care system. Finland is 
divided into mutually exclusive catchment areas among the five 
university hospitals. This system allows the creation of disease cohorts 
that are unselected and minimally biased. 
5.5 CONCLUSION  
Very accurate population statistics and a stable population ensure that 
few patients are lost to follow-up. In conclusion, type 2 diabetes is a risk 
factor for two forms of stroke, brain infarction and intracerebral 
hemorrhage (22-24), but our study suggests that type 2 diabetes does not 
increase the risk of rupture of sIA, which is by far the most frequent 
cause of nontraumatic SAH. 
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6 Hypertension predisposes to the formation 
of saccular intracranial aneurysms in 467 
unruptured and 1053 ruptured patients in 
Eastern Finland 
ABSTRACT 
Objective 
Hypertension associates with subarachnoid hemorrhage from saccular 
intracranial aneurysm (sIA-SAH) when compared to matched controls or 
general population. Few series compare hypertension in unruptured sIA 
carriers vs. sIA-SAH cases, so its real impact on the sIA disease remains 
uncertain. 
Methods 
Kuopio sIA Database (www.uef.fi/ns) contains all cases of unruptured 
and ruptured sIAs admitted to Kuopio University Hospital from its 
Eastern Finnish catchment population. We compared the age-adjusted 
incidence of drug-treated hypertension in 467 unruptured and 1053 
ruptured angiographically verified sIA patients first admitted to KUH 
from 1995 to 2007, using the national registry of prescribed medicines. 
We analyzed whether hypertension associates with the formation or 
growth of sIA rather than rupture. 
Results 
In the unruptured group, 90% presented with hypertension, smoking, 
and/or familial sIA. Antihypertensive medication was more frequent in 
the unruptured group (73% vs. 62%), with higher age-adjusted incidence 
than in the sIA-SAH group. At sIA diagnosis, the sIA-SAH group had 
more often untreated hypertension (29% vs. 23%). The size of unruptured 
sIAs increased with age at sIA diagnosis, independently of hypertension. 
Multiple sIAs, familial sIA and sIA-SAH were not associated with 
hypertension in multivariate analysis. Our findings indicate that drug-
treated hypertension associates with the formation of sIAs rather than 
their growth or rupture. Untreated hypertension may predispose to the 
rupture of sIA.  
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Conclusion 
Hypertension is highly prevalent in carriers of unruptured sIA(s) and it 
associates with the formation of sIA. Our study stresses the importance 
of blood pressure monitoring and control in carriers of unruptured sIAs. 
 
6.1 INTRODUCTION 
About 3% of general population develops saccular intracranial 
aneurysms (sIAs) during life at the forks of intracranial extracerebral 
arteries (1,2). Most do not rupture and are too small to cause neurological 
symptoms by compression. If diagnosed during life, most unruptured 
sIAs are incidental findings in neuroimaging for other causes or 
screening for familial sIAs. The course of the sIA disease involves 
formation (49,74,75), further growth (74,75,144,170), and rupture (3) of 
the sIA pouch. About 95% of aneurysmal subarachnoid hemorrhages are 
caused by the rupture of the sIA wall (sIA-SAH), a devastating form of 
stroke that affects working age population (99). The annual incidence of 
SAH is 4-7 per 100 000 worldwide (4) but over twice as high in Finland 
and in Japan (4). The sIA disease is a complex trait, affected by age, 
female sex, smoking, hypertension, and excess drinking,(5) and by 
genomic factors (6,7)  with at least 10% of ruptured sIA-SAH patients 
having a family history (8,9). 
Hypertension, a complex trait that also affects the arterial wall (25), is 
a strong risk factor for brain infarction and intracerebral hemorrhage 
(23). Antihypertensive medication is essential in their primary and 
secondary prevention (27). Hypertension is significant in the formation 
and growth of sIAs in animal models (46) as well as in small clinical 
series (49,74,75). Hypertension strongly associates with angiographically 
verified sIA-SAH when compared to matched controls or general 
population (Table 6.1) (28-32). Instead, few series compare hypertension 
in unruptured sIA carriers against sIA-SAH cases or unaffected controls 
(28,34-36). 
Kuopio sIA Database (www.uef.fi/ns) contains all cases of unruptured 
and ruptured sIAs admitted to the Kuopio University Hospital (KUH) 
from a defined Eastern Finnish catchment population since 1980 (9). We 
have studied the phenotype (9), familial form (8,9), outcome (37), 
concomitant diseases (40,171), and genomics of the sIA disease (6,7).  Here 
we compared the incidence of drug-treated hypertension in 467 
unruptured and 1053 ruptured sIA patients with first diagnosis between 
1995 and 2007. We analyzed whether hypertension associates with the 
formation or further growth of sIA rather than rupture.  
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6.2 MATERIALS AND METHODS 
6.2.1 Catchment population of Kuopio University Hospital 
During the study period from 1995 to 2007, Neurosurgery of KUH solely 
provided full-time acute and elective neurosurgical services for the KUH 
catchment population in Eastern Finland (171). The KUH area contains 
four central hospitals with neurological units of their own. From 1995 to 
2007, the geographic area remained the same but the population 
decreased from 880 914 to 851 066. The median age increased from 38 to 
42 years in males and from 41 to 45 years in females, and the proportion 
of males remained unchanged at 49%. 
6.2.2 Kuopio Intracranial Aneurysm Database (www.uef.fi/ns) 
All cases of SAH diagnosed by spinal tap or CT in the KUH catchment 
area have been acutely admitted to KUH for angiography and treatment 
if not moribund or very aged. Cases with unruptured IA(s) and no SAH 
have also had neurosurgical consultation for elective occlusion. They 
were detected as incidental findings in neuroimaging for other causes, as 
symptomatic or by screening sIA family members (Table 6.2). The 
findings were confirmed by four vessel catheter angiography, magnetic 
resonance angiography (MRA) or computed tomography angiography 
(CTA). The exact numbers of rejected cases are not available. KUH 
Neurosurgery maintains a database on all cases of unruptured and 
ruptured intracranial aneurysms admitted to the KUH since 1980. The 
database has been prospective since 1990. The database is run by a full-
time nurse, who interviews new cases and codes variables with detailed 
information, including family history. The criterion for sIA family is at 
least two affected first-degree relatives (9). Clinical data from the hospital 
periods and follow-up visits are entered. The use of prescribed 
medications (1995-2008) before and after the sIA diagnosis, cancer and 
other diagnosed diseases, and causes of death have been entered from 
national registries.  
6.2.3 Study Population 
The cohort consisted of 467 unruptured and 1053 ruptured consecutive 
sIA patients, fulfilling the following criteria: a citizen of Finland and 
resident of the KUH catchment area at first diagnosis of sIA disease 
between January 1, 1995, and December 31, 2007; admission alive to 
KUH; verification of sIA(s) by angiography; other intracranial vascular 
malformations (fusiform, traumatic or mycotic aneurysm; moyamoya 
disease; arteriovenous malformation) excluded by angiography; 
autosomal polycystic kidney disease and Marfan’s syndrome excluded.  
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6.2.4 Antihypertensive medication 
The diagnosis of hypertension was made based on purchased 
antihypertensive drugs. The Social Insurance Institution of Finland 
maintains a nationwide registry of all prescribed medicines purchased 
since 1994. Purchases by the 1520 sIA patients between January 1, 1994, 
and December 31, 2008, were obtained from the registry and linked to the 
database. The patient recruitment period from January 1, 1995, to 
December 31, 2007, allows data on the purchased drugs for at least one 
year before and after the sIA diagnosis. Antihypertensive as well as 
antidiabetic and statin medications were classified according to the 
anatomic therapeutic chemical (ATC) classification system. In Finland, 
these drug groups are sold by prescription only. 
6.2.5 Variables 
The variables used in the analyses were (Table 6.3): 
For all sIA patients: 
1. sIA disease carrier (gender; age at first sIA diagnosis; sporadic vs. 
familial sIA patient; use and starting age of antihypertensive, antidiabetic 
and statin medications; current or former smoking vs. none: missing in 
one unruptured and 288 sIA-SAH patients). 
2. sIA disease (location and diameter of the primary sIA; one vs. two or 
more sIAs). 
3. Occlusive therapy (microsurgical vs. endovascular vs. other vs. none). 
For sIA-SAH patients only: 
4. Condition on admission to KUH (Hunt and Hess Scale; intracerebral 
hemorrhage; intraventricular hemorrhage; acute hydrocephalus). 
5. Outcome at 12 months (Glasgow Outcome Scale). 
6.2.6 Review of the literature 
PubMed search on 2.4.2013 for articles published in English after 1.1.2001 
with the terms (subarachnoid* hemorrhage) AND (hypertension OR 
"blood pressure") gave 825 hits. Only (a) case-control studies with (b) 
angiographically verified IAs, (c) age and sex matched controls, and (d) 
multivariate analysis of risk factors were included. Another search with 
the terms aneurysm* AND (intracranial OR cerebral) AND unruptured 
AND (risk factor* OR etiology OR hypertension OR “blood pressure”) 
gave 530 hits. Only studies with angiographically verified IAs were 
included. The reference lists of relevant articles were checked for further 
relevant publications. The most recent study was included from a single 
cohort (Table 6.1). 
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6.2.7 Statistical analysis 
Univariate analyses were performed using the Mann-Whitney U-test or 
the chi-square test. Multivariate analyses were performed using linear 
regression (Figure 6.2) and binomial logistic regression (Table 6.3). P < 
0.05 was considered significant. In the analyses including smoking, cases 
with missing data were excluded. To account for differences of ages at 
sIA diagnosis between the unruptured and ruptured groups, age was 
standardized to the joint age distribution of both age groups. 
Standardized rates and confidence intervals were calculated according to 
Fay et al (165). The incidences of hypertension in the unruptured and 
ruptured groups were calculated for ten-year age intervals, and the 
confidence intervals in each age group were calculated as exact central 
Poisson confidence intervals (166). Age-standardization was done using 
R statistical computing environment and other analyses were made using 
SPSS 19 for Mac. 
6.2.8 Ethical aspects 
The study was approved by the Ethics Committee of the KUH. Data 
fusion from the national registries was performed with the approval 
from Ministry of Social Affairs and Health of Finland. 
RESULTS 
6.3.1 Study cohort 
The entire cohort consisted of 1520 consecutive sIA patients, first 
diagnosed between 1995 and 2007 (Table 6.3). There were 467 
unruptured sIA cases (25% familial) and 1053 sIA-SAH cases (11% 
familial), with total follow-up times of 3074 and 6130 patient-years, 
respectively. Of the 467 unruptured sIA cases, 92% were incidental 
findings (median 6 mm) in neuroimaging while 8% caused neurological 
symptoms mainly by mass effect (median 16 mm) (Table 6.2). The 
cumulative mortality rate at 12 months was 3.9% for the unruptured 
cases and 8.5% for the sIA-SAH cases in good condition on admission 
(Hunt and Hess Grade 1-2) but 42.5% for the sIA-SAH cases in poor 
condition (Hunt and Hess Grade 3-5). 
6.3.2 Hypertension in unruptured vs sIA-SAH patients 
During the observation period for drug use (1994 to 2008), 
antihypertensive medication was used by 73% of the unruptured sIA 
patients in contrast to 62% of the sIA-SAH patients (Table 6.3). The 
medication was started before the sIA diagnosis more often in the 
unruptured group (57% vs. 33%) (Table 6.3). The age-adjusted incidence 
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of hypertension was higher in the unruptured group, 94.5 (CI 95% 87.6 to 
102) vs. 72.5 (CI 95% 68.5 to 76.8) per 1000 follow up years (Figure 6.1). 
The incidence was calculated separately for the sIA-SAH cases with poor 
condition on admission (Hunt and Hess Grade 3-5) because their high 
mortality reduced the percentage of antihypertensive medications started 
after the rupture (Table 6.3, Figure 6.1). Antihypertensive treatment was 
started after the sIA diagnosis in 23% of the unruptured and 29% of the 
sIA-SAH patients (p<0.05).   
6.3.3 Smoking by unruptured vs. sIA-SAH patients 
Current or former smokers until sIA diagnosis were identified in 45% of 
the unruptured sIA cases (62% males, 32% females) and in 42% of the 
sIA-SAH cases (55% males, 32% females; data missing in 27%) (Table 
6.3).  
6.3.4 Hypertension and smoking vs. familial sIA disease 
Familial sIA disease was carried by 25% of the unruptured group (23% 
males, 26% females) and by 11% of the sIA-SAH group (16% males, 12% 
females) (Table 6.3). In multivariate analysis, hypertension or smoking 
were not associated with the familial sIA disease in either group (data 
not shown).  
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Table 6.2 Indications for diagnostic neuroimaging in 467 unruptured sIA 
patients in 1995-2007 from Eastern Finland. 
  No AHTM in follow 
up (n=124) 
AHTM started before 
or after sIA diagnosis 
(n=343) 
Incidental sIA 100 (81%) 283 (83%) 
   Median size (mm) (quartiles) 5 (3-8) 6 (4-9) 
   Headache 19 (15%) 50 (15%) 
   Brain infarction or TIA 4 (3%) 37 (11%) 
   Vertigo 8 (6%) 27 (8%) 
   Amnesia 3 (2%) 15 (4%) 
   Trauma 6 (5%) 14 (4%) 
   Other 56 (45%) 115 (34%) 
   Unknown 4 (3%) 25 (7%) 
      
Screening for familial sIA 15 (12%) 30 (9%) 
    Median size (mm) (quartiles) 5 (3-6) 4 (3-6) 
      
Symptomatic sIA 9 (7%) 30 (9%) 
   Median size (mm) (quartiles) 14 (7-30) 17 (9-28) 
   Vision defect 3 (2%) 12 (3%) 
   Epileptic seizure 0 5 (2%) 
   Hemiparesis 2 (2%) 8 (2%) 
   Other 4 (3%) 5 (2%) 
      
sIA = saccular intracranial aneurysm; AHTM = antihypertensive medication; TIA = 
transient ischemic attack.  
6.3.5 Hypertension and smoking vs. multiple sIAs 
Multiple sIAs (two or more) were diagnosed in 25% of the unruptured 
group (26% males, 25% females) and in 28% of the sIA-SAH group (25% 
males, 30% females) (Table 6.3). In multivariate analysis, hypertension or 
smoking were not associated with multiple sIAs.  
51 
 
 
 
Figure 6.1. Incidence of hypertension in 467 unruptured saccular intracranial 
aneurysm (sIA) patients and 1.053 ruptured ones (sIA-SAH) by the 10-year 
age groups and their 95% confidence intervals. A. Patients with 
antihypertensive medication started before the sIA diagnosis. Follow up time 
ends at the start of antihypertensive medication or the time of sIA diagnosis. 
B. Patients with antihypertensive medication started before or after the sIA 
diagnosis. Follow up time ends at the start of antihypertensive medication, 
death or 31.12.2008. 
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Figure 6.2 Correlation of the age at diagnosis with the diameter of 
unruptured saccular intracranial aneurysms (sIAs) and ruptured ones (sIA-
SAH). Regression lines and 95% confidence intervals (CIs) are shown for 
unruptured (continuous lines) and ruptured (dotted lines) patients. The 
patients (A) without vs. (B) with antihypertensive medication during follow 
up as well as the patients (C) without vs. (D) with history of smoking 
(former or current) until the sIA diagnosis. The unruptured sIAs that caused 
symptoms were removed from the analysis. 
6.3.6 Hypertension and smoking vs. size of sIA at first diagnosis 
The size at diagnosis of the incidentally found unruptured sIAs in 428 
patients (Table 6.2) increased with age (Figure 6.2), independently of 
gender, familial sIA disease, hypertension or smoking in multivariate 
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analysis (0.10 mm/year; CI95% 0.048-0.154; p < 0.001). In comparison, the 
size of the ruptured sIAs did not increase significantly with the age at 
first diagnosis (0.03 mm/year; CI95% -0.001 – 0.054; p=0.06).  
6.4 DISCUSSION 
6.4.1 Essential findings 
We studied the incidence of hypertension in 467 unruptured sIA patients 
as compared to 1053 sIA-SAH patients, first diagnosed between 1995 and 
2007 and admitted to KUH that solely serves a defined Eastern Finnish 
catchment population. Only 10% of the unruptured group did not 
present with hypertension, smoking, or familial sIA disease, independent 
risk factors for the sIA disease (5). In total, 73% of the unruptured sIA 
patients and 62% of the sIA-SAH patients had purchased 
antihypertensive medication between 1994 and 2008,(171) at least one 
year before or after the sIA diagnosis. The lower overall percentage of 
hypertension in sIA-SAH patients may partially relate to their higher 12-
month mortality. The age-adjusted incidence of hypertension was higher 
in the unruptured sIA group than in the sIA-SAH group (Figure 6.1). The 
size of unruptured sIAs increased with the age at sIA diagnosis (Figure 
6.2), independently of hypertension. Multiple sIAs, familial sIA disease 
or sIA-SAH were not associated with hypertension in multivariate 
analysis either.  Firstly, our findings indicate that hypertension is 
strongly associated with the formation of sIA. Secondly, untreated 
hypertension may predispose to the rupture of sIA wall (36), because at 
the time of sIA diagnosis the sIA-SAH patients had significantly more 
often untreated hypertension (see the columns `AHTM started after sIA 
diagnosis` in Table 6.3). 
6.4.2 Hypertension and sIA disease 
One would expect that independent risk factors of the sIA disease would 
predispose to earlier age, larger size and multiple sIAs at diagnosis. 
Smoking predisposes to SAH (5,85), even showing synergy with 
hypertension (78), and smoking is a risk factor for the de novo sIA 
formation verified angiographically (49,74,75). The mechanisms by which 
hypertension would affect the formation, further growth, or rupture of 
the sIA pouch have remained uncertain. In previous angiographically 
verified sIA series, hypertension has strongly associated with sIA-SAH 
when compared to matched controls or general population (Table 1), 
suggesting that hypertension would predispose the sIA wall to rupture. 
However, few series have compared unruptured sIA patients to controls 
or to sIA-SAH patients (Table 6.1). In a case-control study of 250 
  
 
56 
aneurysmal SAH patients (25% hypertensive) and 206 unruptured IA 
patients (38% hypertensive), hypertension was not a significant risk 
factor for rupture (36). In a Japanese case-control study, 53% of the 858 
ruptured and 58% of the 285 unruptured sIA patients had a history of 
hypertension until the sIA diagnosis as compared to 30% in 798 controls 
(28). The author concluded that hypertension associates with the 
formation of sIAs rather than their rupture.  
6.4.3 Hypertension in unruptured sIA patients 
In the UCAS study, 43.4% of the 5720 unruptured sIA patients (91% 
incidental; mean age 62.5 years; 68% women; no previous SAH) had a 
history of hypertension before the angiographic sIA diagnosis.(90) 
Hypertension did not significantly associate with subsequent rupture of 
the sIAs (HR 1.41; CI95% 0.96–2.07). In ISUIA study, 41% of the 4060 
angiographically verified unruptured sIA patients had a history of 
hypertension before the angiographic diagnosis (91). Hypertension was 
not a significant risk factor for the sIA rupture either. In a recent study of 
206 unruptured IA patients and 574 controls, 38% and 19% had a history 
of hypertension, respectively. Hypertension was a significant risk factor 
for unruptured sIA in multivariate analysis (OR 2.9;1-4.6) (35). In our 
study, hypertension was detected in 52% before the sIA diagnosis, 
tallying with previous studies. Hypertension was detected in further 23% 
after the sIA diagnosis, a trend unnoticed previously. In the national 
FINRISK study, only 56.2% to 74.5% of participants in the KUH 
catchment area were aware of their hypertension (151). 
6.4.4 Hypertension and unruptured sIA growth 
In animal models, hypertension is essential both in the formation and 
further growth of sIAs (46). Few clinical series have correlated 
hypertension to the growth of unruptured sIAs between two 
angiographies. Hypertension was significantly associated with growth in 
a retrospective series of 53 sIAs (74), but not in a retrospective series of 
165 patients (144) and a prospective series of 87 patients (75). 
The size of unruptured sIAs increases with the age at diagnosis (9), 
probably due to longer exposure to modifiable risk factors. In our study, 
the size of unruptured sIAs increased with age at diagnosis, irrespective 
of hypertension or smoking. 
6.4.5 Hypertension and familial sIA disease 
The sIA disease is a complex trait, and at least 10% of cases are familial 
(8,9) 25% of the unruptured and 11% of the ruptured patients in the 
present series. Possible genomic or epigenomic mechanisms behind the 
familial form are unknown. A putative sIA risk locus at 5q26 associates 
with high systolic blood pressure but leading hypertension risk loci did 
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not associate with the sIA disease in Finland (7). In the Nordic Twin 
Cohort, the concordance for SAH diagnoses from national hospital 
discharge registers was only 3.1% in monozygotic twins, but data for 
unruptured cases was unavailable (71). Korja et al. suggested that 
familial clustering of modifiable risk factors, e.g. smoking, high blood 
pressure, and heavy alcohol consumption, significantly contribute to 
familial SAH (71). In our series, hypertension or smoking were not 
associated with familial sIA among the unruptured or ruptured patients. 
6.4.6 Hypertension and multiple sIAs 
Hypertension was significantly associated with the presence of multiple 
(two or more) intracranial aneurysms in 392 ruptured patients (OR 1·9, 
95% CI 1·5–3·5) (77), but not in 298 ruptured and 121 unruptured patients 
(139), nor in 266 ruptured patients (76). In our study, hypertension or 
smoking were not associated with multiple sIAs. 
6.4.7 Weaknesses and strengths of the present study  
In the present study, blood pressure was not monitored prospectively, 
but the hypertension diagnosis was based on the purchase of prescribed 
antihypertensive medicines. Higher 12-month mortality of sIA-SAH 
patients may have reduced the incidence of hypertension detectable after 
sIA-SAH.  Of the unruptured sIA cases, 92% seemed incidental findings, 
but hypertension may have affected indications for neuroimaging.  
There are several strengths that derive from the Scandinavian health 
care system. Finland is divided into exclusive catchment areas for the 
five university hospitals, allowing cohorts that are unselected and 
minimally biased. Accurate population statistics and stable population 
ensure that few patients are lost to follow-up. Our series contains 
angiographically verified sIA cases only, while several series have 
included other forms of intracranial aneurysms and non-aneurysmal 
cases of SAH, or were based on archival ICD codes only. We carefully 
analyzed the reasons for diagnostic imaging in unruptured cases. In 
Finland, antihypertensive medications are sold by prescription only, and 
the purchases are available in the national registry. In previous studies, 
hypertension diagnosis was often made based on previous history or 
interview, and the hypertension status was not updated during follow-
up after the initial sIA diagnosis.  
6.4.8 Suggested further research 
sIAs form during life at the branching sites of intracranial extracerebral 
arteries, in the so-called medial raphe (172), the seal between the medial 
arterial walls of the two daughter branches when they originate from the 
mother branch. Fetal development of branching tubular trees in various 
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organs, branching morphogenesis, has not been elucidated in intracranial 
extracerebral arteries. 
Two obvious clinical questions arise. Firstly, can the formation of sIAs 
be prevented by antihypertensive medication? Hardly if hypertension is 
an inborn complex trait that affects the arterial walls and the medial 
raphe area, in particular, long before the rise of measured blood pressure 
values that finally trigger the start of medication. Possibly if the sIA 
pouch formation is actually caused by elevated blood pressure, but even 
then it is demanding to design reliable population-based studies, and 
none exist, so far. Unruptured sIAs are in most cases incidental findings 
in neuroimaging for other reasons. Secondly, is it reasonable, cost 
effective and ethically sound to screen unruptured sIAs by MRA or CTA 
after fresh diagnoses of hypertension?  
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7 General discussion  
7.1 TEMPORAL PATTERNS IN THE INCIDENCE OF SIA-
SAH  
Sundays and Mondays were the most frequent and Saturdays the least 
frequent days of sIA-SAH occurrence. This was not affected by the 
admission pattern or the time of occlusive therapy. We could not identify 
any etiology to this temporal pattern. Binge drinking, concentrating at 
the weekends, is frequent in Finland, especially among young males, but 
age and gender did not correlate with the Sunday and Monday peaks.  
Heavy alcohol consumption is a risk factor for all types of stroke, and 
the habit of binge drinking is considered to be an additional independent 
risk factor. In Finland, the alcohol consumption per capita ratio was 10.2 
in 2009, the second highest in the Nordic countries. Alcohol intake in 
Finland concentrates on the weekends, and the highest levels of binge 
drinking and drunkenness in the EU are found in Finland.  
In theory, the beginning of a new working week on Monday could 
cause stress-related physiological changes in the body, triggering sIA-
SAH. This was supported by the finding in our cohort that age over 65 
years, indicating retirement, diluted the Sunday and Monday peaks, 
although not significantly. Changes in physical activity between working 
days and weekends could also be a factor. 
Further research is needed to elucidate factors causing the observed 
temporal sIA-SAH incidence pattern.  
 
7.2 IMPACT OF TYPE 2 DIABETES ON THE RISK OF SIA-
SAH  
The incidence of type 2 diabetes was highest in the age group 60–70 
years, with no significant differences between the sIA-SAH group and 
unruptured sIA group. Our study indicates that type 2 diabetes does not 
increase the risk of sIA-SAH. 
Unlike our study, three recent studies (28,29,140) suggest that diabetes 
is a protective factor for aSAH. Increased atherosclerosis induced by 
diabetes in the intracranial arteries was suggested as the cause for 
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reduced sIA-SAH risk (28), but there is no data to support this 
hypothesis. Hypercholesterolemia was associated with a reduced risk of 
aSAH in two recent studies (28,36), but the risk reduction may be caused 
by the use of statins. The independent role of statins in the prevention of 
sIA-SAH is difficult to differentiate because the use of statins is 
associated with the use of antihypertensive and antidiabetes medications. 
Another protective factor of sIA-SAH in diabetic patients might be more 
efficient diagnosis and treatment of hypertension, an independent risk 
factor of sIA disease.  
 
7.3 IMPACT OF HYPERTENSION ON THE SIA DISEASE 
From 1994 to 2008, only 10% of the unruptured sIA patients did not 
present with hypertension, smoking, or familial sIA. Antihypertensive 
medication was more frequent in the unruptured sIA group (73% vs. 
62%), with higher age-adjusted incidence than in the sIA-SAH group. At 
sIA diagnosis, more of the sIA-SAH group had untreated hypertension 
(29% vs. 23%). Size of unruptured sIAs increased with the age at sIA 
diagnosis, independently of hypertension. Multiple sIAs, familial sIA 
and sIA-SAH were not associated with hypertension in the multivariate 
analysis.  
Previous data indicated that hypertension is a risk factor for aSAH, 
even having  synergistic effect with smoking (5,78). However, the 
prevalence of hypertension has been rarely studied in unruptured sIA 
patients vs. controls or sIA-SAH patients from the same population. The 
few existing studies of hypertension in unruptured sIA patients suggest 
that hypertension is a risk factor for sIA formation rather than its rupture 
(28,35). In animal models of intracranial aneurysms, externally induced 
hypertension is essential in the induction of aneurysm formation. (46)  
Our study indicates that hypertension has a significant role in the 
formation of sIAs rather than their rupture. Can the formation of sIAs be 
prevented by antihypertensive medication at population level, with the 
lifetime sIA prevalence of 3%? Hardly, if hypertension is an inborn 
complex trait that affects the arterial walls and the medial raphe area 
(172), the phenotypic target tissue of the sIA disease in particular, long 
before the rise of measured blood pressure values that finally trigger the 
start of medication. Possibly, if sIA pouch formation is actually caused by 
elevated blood pressure. However, even then it is demanding to design 
reliable population-based studies to assess the efficacy of 
antihypertension medication in the prevention of sIA formation.  
On the other hand, drug-treated hypertension does not seem to be a 
risk factor for sIA-SAH. Cardiovascular morbidity and mortality increase 
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as blood pressure become elevated, without a definite treshold value. 
Currently, there are no guidelines for antihypertensive treatment in 
patients with unruptured sIA or previous sIA-SAH (117,122,131). Should 
sporadic or familial sIA patients with hypertension be treated according 
to the lower goal pressures that are recommended in the current 
cardiovascular prevention guidelines for those with high cardiovascular 
risk or previous cardiovascular events (143)?  
Unruptured sIAs are in most cases incidental findings in 
neuroimaging for other reasons. Should patients with diagnosed 
hypertension  be screened by CTA or MRA for incidental sIAs? Is such 
screening reasonable, ethical and cost-effective in the age of brain? 
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8 Conclusions 
I 
Sundays and Mondays were the most frequent and Saturdays the least 
frequent days of sIA-SAH occurrence. We could not identify any etiology 
to this temporal pattern.  
 
II 
 
Our study indicates that type 2 diabetes does not increase the risk of sIA-
SAH.  
III  
 
Our study indicates that hypertension is associated with the formation of 
sIA pouches rather than their growth or rupture. Untreated hypertension 
may predispose to the rupture of sIA wall. Our study further stresses the 
importance of careful blood pressure monitoring and control in the 
carriers of unruptured sIAs. 
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Saccular intracranial aneurysms 
(sIAs) are balloon-like vascular 
bulges that develop at branching 
points of intacranial arteries in ap-
proximately 3% of the population 
during life. The rupture of sIA wall 
is the most frequent cause of aneu-
rysmal subarachnoid hemorrhage 
(aSAH), a devastating form of stroke 
that mainly affects the working-age 
population. This study is a part of the 
long-term research effort of Kuopio 
sIA Database to characterize Eastern 
Finnish sIA disease.  In the present 
study, we used an overall cohort of 
2904 consecutive sIA patients from 
1980 to 2007 to analyze temporal pat-
terns of aSAH incidence and the role 
of type 2 diabetes and hypertension 
in sIA disease.
